Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein.
H Lilja
H Lilja
Published November 1, 1985
Citation Information: J Clin Invest. 1985;76(5):1899-1903. https://doi.org/10.1172/JCI112185.
View: Text | PDF
Research Article Article has an altmetric score of 9

A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein.

  • Text
  • PDF
Abstract

A 33-kD glycoprotein, known as the "prostate-specific antigen," was purified to homogeneity from human seminal plasma. The prostatic protein was identified as a serine protease, and its NH2-terminal sequence strongly suggests that it belongs to the family of glandular kallikreins. The structural protein of human seminal coagulum, the predominant protein in seminal vesicle secretion, was rapidly cleaved by the prostatic enzyme, which suggests that this seminal vesicle protein may serve as the physiological substrate for the protease. The prostatic enzyme hydrolyzed arginine- and lysine-containing substrates with a distinct preference for the former. All synthetic substrates tested were poor substrates for the enzyme. Synthetic Factor XIa substrate (pyro-glutamyl-prolyl-arginine-p-nitroanilide), and the synthetic kallikrein substrate (H-D-prolyl-phenylalanyl-arginine-p-nitroanilide) were hydrolyzed with maximum specific activities at 23 degrees C of 79 and 34 nmol/min per mg and Km values of 1.0 and 0.45 mM, respectively. Synthetic substrates for plasmin, chymotrypsin, and elastase were either not hydrolyzed by the enzyme at all, or only hydrolyzed very slowly.

Authors

H Lilja

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 Total
Citations: 2 4 6 3 9 7 6 5 12 10 10 13 12 7 20 10 27 18 20 10 15 11 16 16 21 15 20 21 33 26 23 19 16 15 15 14 17 8 8 2 542
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (542)

Title and authors Publication Year
Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves prediction across ancestry groups
Hoffmann TJ, Graff RE, Madduri RK, Rodriguez AA, Cario CL, Feng K, Jiang Y, Wang A, Klein RJ, Pierce BL, Eggener S, Tong L, Blot W, Long J, Goss LB, Darst BF, Rebbeck T, Lachance J, Andrews C, Adebiyi AO, Adusei B, Aisuodionoe-Shadrach OI, Fernandez PW, Jalloh M, Janivara R, Chen WC, Mensah JE, Agalliu I, Berndt SI, Shelley JP, Schaffer K, Machiela MJ, Freedman ND, Huang WY, Li SA, Goodman PJ, Till C, Thompson I, Lilja H, Ranatunga DK, Presti J, Van Den Eeden SK, Chanock SJ, Mosley JD, Conti DV, Haiman CA, Justice AC, Kachuri L, Witte JS
Nature Genetics 2025
Comparative functional analyses of the prostate-specific KLK3 enzyme in primates reveal the impact of sexual selection
Kahveci EF, Colvin Zielen AM, Gibbs WJ, McIntyre CA, Modi R, Johnstonbaugh HZ, Washington TH IV, Brown DR V, Hockman MR, Rossman NR, Jensen-Seaman MI
Evolution; International Journal of Organic Evolution 2025
Application and optimization of prostate-specific antigen screening strategy in the diagnosis of prostate cancer: a systematic review.
Zhang Z, Tian A, Che J, Miao Y, Liu Y, Liu Y, Xu Y
Frontiers in Oncology 2024
Biosensors for Cancer Biomarkers Based on Mesoporous Silica Nanoparticles.
Mladenović M, Jarić S, Mundžić M, Pavlović A, Bobrinetskiy I, Knežević NŽ
Biosensors 2024
Transcriptome-wide association analysis identifies candidate susceptibility genes for prostate-specific antigen levels in men without prostate cancer
Chen DM, Dong R, Kachuri L, Hoffmann TJ, Jiang Y, Berndt SI, Shelley JP, Schaffer KR, Machiela MJ, Freedman ND, Huang WY, Li SA, Lilja H, Justice AC, Madduri RK, Rodriguez AA, Van Den Eeden SK, Chanock SJ, Haiman CA, Conti DV, Klein RJ, Mosley JD, Witte JS, Graff RE
2024
A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer.
Srinivasan S, Kryza T, Bock N, Tse BWC, Sokolowski KA, Janaththani P, Fernando A, Moya L, Stephens C, Dong Y, Röhl J, Alinezhad S, Vela I, Perry-Keene JL, Buzacott K, Nica R, Gago-Dominguez M, Schleutker J, Maier C, Muir K, Tangen CM, Gronberg H, Pashayan N, Albanes D, Wolk A, Stanford JL, Berndt SI, Mucci LA, Koutros S, Cussenot O, Sorensen KD, Grindedal EM, Travis RC, Haiman CA, MacInnis RJ, Vega A, Wiklund F, Neal DE, Kogevinas M, Penney KL, Nordestgaard BG, Brenner H, John EM, Gamulin M, Claessens F, Melander O, Dahlin A, Stattin P, Hallmans G, Häggström C, Johansson R, Thysell E, Rönn AC, Li W, Brown N, Dimeski G, Shepherd B, Dadaev T, Brook MN, Spurdle AB, Stenman UH, Koistinen H, Kote-Jarai Z, Klein RJ, Lilja H, Ecker RC, Eeles R, Clements J, Batra J
Nature communications 2024
Biochemical activity induced by a germline variation in KLK3 (PSA) associates with cellular function and clinical outcome in prostate cancer.
Batra J, Sriniva S, Kryza T, Bock N, Tse BW, Sokolowski KA, Clements J
Research square 2023
The roles of proteases in prostate cancer.
Koistinen H, Kovanen RM, Hollenberg MD, Dufour A, Radisky ES, Stenman UH, Batra J, Clements J, Hooper JD, Diamandis E, Schilling O, Rannikko A, Mirtti T
IUBMB Life 2023
Extent of N-Terminus Folding of Semenogelin 1 Cleavage Product Determines Tendency to Amyloid Formation.
Osetrina DA, Kusova AM, Bikmullin AG, Klochkova EA, Yulmetov AR, Semenova EA, Mukhametzyanov TA, Usachev KS, Klochkov VV, Blokhin DS
International journal of molecular sciences 2023
Genetically adjusted PSA levels for prostate cancer screening.
Kachuri L, Hoffmann TJ, Jiang Y, Berndt SI, Shelley JP, Schaffer KR, Machiela MJ, Freedman ND, Huang WY, Li SA, Easterlin R, Goodman PJ, Till C, Thompson I, Lilja H, Van Den Eeden SK, Chanock SJ, Haiman CA, Conti DV, Klein RJ, Mosley JD, Graff RE, Witte JS
Nature Medicine 2023
Designed ankyrin repeat proteins for detecting prostate-specific antigen expression in vivo.
Gut M, Dreier B, Furler S, Sobek J, Plückthun A, Holland JP
2023
Evaluation of Semen Self-Sampling Yield Predictors and CTC Isolation by Multi-Color Flow Cytometry for Liquid Biopsy of Localized Prostate Cancer.
Saitta C, De Simone I, Fasulo V, Corbetta M, Duga S, Chiereghin C, Colombo FS, Benetti A, Contieri R, Avolio PP, Uleri A, Saita A, Guazzoni GF, Hurle R, Colombo P, Buffi NM, Casale P, Lughezzani G, Asselta R, Soldà G, Lazzeri M
Cancers 2023
Blocking serine protease activity prevents semenogelin degradation leading to hyperviscous semen in humans.
Anamthathmakula P, Erickson JA, Winuthayanon W
Biology of reproduction 2022
Circulating Biomarkers for Therapeutic Monitoring of Anti-cancer Agents.
Janse van Rensburg HJ, Spiliopoulou P, Siu LL
The oncologist 2022
Untargeted Metabolomics Study of Three Matrices: Seminal Fluid, Urine, and Serum to Search the Potential Indicators of Prostate Cancer.
Buszewska-Forajta M, Raczak-Gutknecht J, Struck-Lewicka W, Nizioł M, Artymowicz M, Markuszewski M, Kordalewska M, Matuszewski M, Markuszewski MJ
Frontiers in Molecular Biosciences 2022
Cancer Vaccines, Adjuvants, and Delivery Systems
SJ Paston, VA Brentville, P Symonds, LG Durrant
Frontiers in immunology 2021
KLK3 in the Regulation of Angiogenesis—Tumorigenic or Not?
H Koistinen, J Künnapuu, M Jeltsch
International journal of molecular sciences 2021
Screening for new peptide substrates for the development of albumin binding anticancer pro-drugs that are cleaved by prostate-specific antigen (PSA) to improve the anti tumor efficacy
BE Elsadek, MH Hassan
Biochemistry and Biophysics Reports 2021
A Conjugation Strategy to Modulate Antigen Binding and FcRn Interaction Leads to Improved Tumor Targeting and Radioimmunotherapy Efficacy with an Antibody Targeting Prostate-Specific Antigen
OV Timmermand, A Örbom, M Altai, W Zedan, B Holmqvist, M Safi, TA Tran, SE Strand, J Strand
Cancers 2021
Microenvironment of the male and female reproductive tracts regulate sperm fertility: Impact of viscosity, pH, and osmolality
M Lavanya, S Selvaraju, B Krishnappa, N Krishnaswamy, G Nagarajan, H Kumar
Andrologia 2021
Identification of Novel Anticancer Agent by in silico Methods for Inhibition of KLK-12 Protein
J Bandi, N Nambigari
2021
Mipsagargin: The Beginning-Not the End-of Thapsigargin Prodrug-Based Cancer Therapeutics.
Isaacs JT, Brennen WN, Christensen SB, Denmeade SR
Molecules (Basel, Switzerland) 2021
Humanization, Radiolabeling and Biodistribution Studies of an IgG1-Type Antibody Targeting Uncomplexed PSA for Theranostic Applications.
Strand J, Sjöström K, Lamminmaki UJ, Vilhelmsson Timmermand O, Strand SE, Tran TA
Pharmaceuticals (Basel, Switzerland) 2021
Facile Synthesis of Pd-Ir Nanocubes for Biosensing.
Li J, Li Y
Frontiers in Chemistry 2021
Role of Kinins in Hypertension and Heart Failure
S Hamid, IA Rhaleb, KM Kassem, NE Rhaleb
Pharmaceuticals (Basel, Switzerland) 2020
Serine protease inhibitor disrupts sperm motility leading to reduced fertility in female mice†
BE Barton, JK Rock, AM Willie, EA Harris, RM Finnerty, GG Herrera, P Anamthathmakula, W Winuthayanon
Biology of reproduction 2020
Mechanism of semen liquefaction and its potential for a novel non-hormonal contraception†
P Anamthathmakula, W Winuthayanon
Biology of reproduction 2020
Human Semenogelin 1 Promotes Sperm Survival in the Mouse Female Reproductive Tract
D Sakaguchi, K Miyado, T Iwamoto, H Okada, K Yoshida, W Kang, M Suzuki, M Yoshida, N Kawano
International journal of molecular sciences 2020
“Emerging role of Novel Seminal Plasma Bio-markers in Male Infertility: A Review”
N Kumar, NK Singh
European journal of obstetrics, gynecology, and reproductive biology 2020
Effect of prostate volume on f/tPSA value: A cross‐sectional study
XH Xu, ZH Xu, MZ Yuan, Y Guan, ST Zhao
Andrologia 2020
Dithiocarbamate prodrugs activated by prostate specific antigen to target prostate cancer
S Bakthavatsalam, P Wiangnak, DJ George, T Zhang, KJ Franz
Bioorganic & Medicinal Chemistry Letters 2020
Beyond the biomarker role: prostate-specific antigen (PSA) in the prostate cancer microenvironment
A Moradi, S Srinivasan, J Clements, J Batra
Cancer and Metastasis Reviews 2019
Characterization of seminal plasma proteomic alterations associated with the IVF and rescue‐ICSI pregnancy in assisted reproduction
X Liu, G Liu, P Zhu, Y Wang, J Wang, W Zhang, W Wang, N Li, X Wang, C Zhang, J Liu, X Shen, F Liu
Andrologia 2019
Association of semenogelin (SEMG) gene variants in idiopathic male infertility in Chinese-Han population
J Wu, X Dong, K Liu, Y Xia, X Wang, O Shen, X Ding, J Zhang
Journal of Toxicology and Environmental Health, Part A 2019
Continued provision of WHO International Standards for total and free PSA: Content and commutability of replacement preparations
J Ferguson, D Patel, E Atkinson, P Rigsby, C Burns
Clinical Biochemistry 2019
Kallikarein‐related peptidase 3 common genetic variant and the risk of prostate cancer
RK Motamedi, N Sarhangi, M Afshari, M Sattari, SH Jamaldini, M Samzadeh, SA Ziaei, GR Pourmand, M Hasanzad
Journal of Cellular Biochemistry 2019
Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues.
Bonk S, Kluth M, Hube-Magg C, Polonski A, Soekeland G, Makropidi-Fraune G, Möller-Koop C, Witt M, Luebke AM, Hinsch A, Burandt E, Steurer S, Clauditz TS, Schlomm T, Perez D, Graefen M, Heinzer H, Huland H, Izbicki JR, Wilczak W, Minner S, Sauter G, Simon R
Oncotarget 2019
A novel prostate cancer immunotherapy using prostate-specific antigen peptides and Candida skin test reagent as an adjuvant
AO Abdallah, H Coleman, M Kamel, R Davis, T Landrum, H Spencer, S Mackintosh, FA Mahmoud, N Milojkovic, C Wicker, K Arnaoutakis, M Nakagawa
SAGE Open Medicine 2018
PSA-alpha-2-macroglobulin complex is enzymatically active in the serum of patients with advanced prostate cancer and can degrade circulating peptide hormones
MB Kostova, WN Brennen, D Lopez, L Anthony, H Wang, E Platz, SR Denmeade
The Prostate 2018
PSA-selective activation of cytotoxic human serine proteases within the tumor microenvironment as a therapeutic strategy to target prostate cancer
OC Rogers, L Anthony, MD Rosen, NW Brennen, SR Denmeade
Oncotarget 2018
Discovery of novel transcripts of the human tissue kallikrein (KLK1) and kallikrein-related peptidase 2 (KLK2) in human cancer cells, exploiting Next-Generation Sequencing technology
PG Adamopoulos, CK Kontos, A Scorilas
Genomics 2018
Stable-protein Pair Analysis as A Novel Strategy to Identify Proteomic Signatures: Application To Seminal Plasma From Infertile Patients
F Barrachina, M Jodar, D Delgado-Dueñas, A Soler-Ventura, JM Estanyol, C Mallofré, JL Ballescà, R Oliva
Molecular & cellular proteomics : MCP 2018
Management of Prostate Cancer
M Bolla, H Poppel
Management of Prostate Cancer 2017
Imaging and Focal Therapy of Early Prostate Cancer
TJ Polascik
Imaging and Focal Therapy of Early Prostate Cancer 2017
Pathophysiological Aspects of Proteases
S Chakraborti, NS Dhalla
Pathophysiological Aspects of Proteases 2017
Methyl Jasmonate Ameliorates Testosterone Propionate-induced Prostatic Hyperplasia in Castrated Wistar Rats: Methyl Jasmonate Ameliorates Prostatic Hyperplasia
OO Akanni, OJ Abiola, OA Adaramoye
Phytotherapy research : PTR 2017
Clinical Reproductive Medicine and Surgery
T Falcone, WW Hurd
2017
Mutations in the prostate specific antigen (PSA/KLK3) correlate with male infertility
N Gupta, DV Sudhakar, PK Gangwar, SN Sankhwar, NJ Gupta, B Chakraborty, K Thangaraj, G Gupta, S Rajender
Scientific Reports 2017
Matrix metalloproteinase and heparin-stimulated serine proteinase activities in post-prostate massage urine of men with prostate cancer
D Muñoz, MK Serrano, ME Hernandez, R Haller, T Swanson, JW Slaton, AA Sinha, MJ Wilson
Experimental and Molecular Pathology 2017
Biomarkers of Outcome in Patients With Localized Prostate Cancer Treated With Radiotherapy
WA Hall, CA Lawton, AB Jani, A Pollack, FY Feng
Seminars in radiation oncology 2017
Significance of the −2propsa index and the prostate health index in patients with prostate cancer: A literature review and data of the Russian prospective study
KB Kolontarev, DY Pushkar, AV Govorov, AV Sidorenkov, TA Osipova, SA Sheptunov
2017
Differential diagnostics of female “sexual” fluids: a narrative review
Z Pastor, R Chmel
International Urogynecology Journal 2017
Enzyme catalysis: the case of the prostate-specific antigen
M Gioia, L Tomao, D Sbardella, C Ciaccio, GR Tundo, AD Masi, GF Fasciglione, S Marini, P Cozza, P Ascenzi, M Coletta
REND LINCEI-SCI FIS 2017
Differential diagnostics of female “sexual” fluids: a narrative review
Zlatko, R Chmel
International Urogynecology Journal 2017
The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance
JC Zarif, CK Miranti
Cellular Signalling 2016
Virtual Screening of Small Drug-Like Compounds Stimulating the Enzymatic Activity of Kallikrein-Related Peptidase 3 (KLK3)
H Ylikangas, JM Mattsson, UH Stenman, H Koistinen, A Poso, M Lahtela-Kakkonen
ChemMedChem 2016
Biomarkers in localized prostate cancer
M Ferro, C Buonerba, D Terracciano, G Lucarelli, V Cosimato, D Bottero, VM Deliu, P Ditonno, S Perdonà, R Autorino, I Coman, SD Placido, GD Lorenzo, OD Cobelli
Future Oncology 2016
4-Kallikrein Test and Kallikrein Markers in Prostate Cancer Screening
ML McDonald, JK Parsons
Urologic Clinics of North America 2016
Mutational Analysis of Prostate-Specific Antigen Defines the Intrinsic Proteolytic Activity of the proPSA Zymogen: Intrinsic Activity of proPSA
N Sangster-Guity, B Tu-Sekine, DM Raben, SR Denmeade, SA Williams
The Prostate 2016
Usefulness of Total PSA Value in Prostate Diseases Diagnosis
A Prcic, E Begic, Hiros
Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : časopis Društva za medicinsku informatiku BiH 2016
Tartrate inhibition of prostatic acid phosphatase improves seminal fluid metabolite stability
MJ Roberts, JP Hattwell, CW Chow, M Lavin, GK Pierens, RA Gardiner, HJ Schirra
Metabolomics 2016
Novel biomarkers for the detection of prostate cancer
NA Jakobsen, FC Hamdy, RJ Bryant
Journal of Clinical Urology 2016
The Prostate Cancer Dilemma
NN Stone, ED Crawford
2016
The Overactive Pelvic Floor
A Padoa, TY Rosenbaum
2016
Advances in Cancer Biomarkers
R Scatena
2015
Advances in Cancer Biomarkers
R Scatena
2015
Advances in Cancer Biomarkers
R Scatena
2015
Advances in Cancer Biomarkers
R Scatena
2015
Molecular imaging of prostate cancer: translating molecular biology approaches into the clinical realm
HA Vargas, J Grimm, OF Donati, E Sala, H Hricak
European Radiology 2015
Seminal fluid: a useful source of prostate cancer biomarkers?
MJ Roberts, RS Richards, RA Gardiner, LA Selth
Biomarkers in Medicine 2015
Phage display aided improvement of a unique prostate-specific antigen (PSA) antibody unreactive with Lys145–Lys146 internally cleaved forms
MF Liton, M Peltola, M Vehniäinen, E Kuusela, T Pettersson, U Lamminmäki, K Pettersson, EC Brockmann
Journal of Immunological Methods 2015
Anti-angiogenic activity of PSA-derived peptides: Anti-angiogenic Activity of PSA-derived Peptides
KC Chadha, B Nair, A Godoy, R Rajnarayanan, E Nabi, R Zhou, NR Patel, R Aalinkeel, SA Schwartz, GJ Smith
The Prostate 2015
Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer
G O'Hurley, C Busch, L Fagerberg, BM Hallström, C Stadler, A Tolf, E Lundberg, JM Schwenk, K Jirström, A Bjartell, WM Gallagher, M Uhlén, F Pontén, N Kyprianou
PloS one 2015
Drug Discovery Series
S Ohkubo
Drug Discovery Series 2015
Comprehensive Physiology
SN Cheuvront, RW Kenefick
Comprehensive Physiology 2014
Kallikreins as Biomarkers for Prostate Cancer
SK Hong
BioMed Research International 2014
Proteomic analysis of patient tissue reveals PSA protein in the stroma of benign prostatic hyperplasia: PSA Protein in BPH Stroma
KJ O'Malley, K Eisermann, LE Pascal, AV Parwani, T Majima, L Graham, K Hrebinko, M Acquafondata, NA Stewart, JB Nelson, N Yoshimura, Z Wang
The Prostate 2014
Seminal plasma as a diagnostic fluid for male reproductive system disorders
AP Drabovich, P Saraon, K Jarvi, EP Diamandis
Nature Reviews Urology 2014
Emerging PSA-Based Tests to Improve Screening
RJ Bryant, H Lilja
Urologic Clinics of North America 2014
Targeted Prodrug Approaches for Hormone Refractory Prostate Cancer: TARGETED PRODRUG APPROACHES
H Aloysius, L Hu
Medicinal Research Reviews 2014
Proteolytic Activity of Prostate-Specific Antigen (PSA) towards Protein Substrates and Effect of Peptides Stimulating PSA Activity
Johanna M. Mattsson, Suvi Ravela, Can Hekim, Magnus Jonsson, Johan Malm, Ale Närvänen, Ulf-Håkan Stenman, Hannu Koistinen
PloS one 2014
Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer
Jason Wu, Dongfeng Pan, Leland W K Chung
Translational andrology and urology 2014
Analysis of Prostate-Specific Antigen Transcripts in Chimpanzees, Cynomolgus Monkeys, Baboons, and African Green Monkeys
JN Mubiru, AS Yang, C Olsen, S Nayak, CB Livi, EJ Dick, M Owston, M Garcia-Forey, RE Shade, J Rogers, AA Aboobaker
PloS one 2014
Characterization of the Prostate-Specific Antigen (PSA) Catalytic Mechanism: A Pre-Steady-State and Steady-State Study
L Tomao, D Sbardella, M Gioia, AD Masi, S Marini, P Ascenzi, M Coletta, A Lodola
PloS one 2014
Proteomic Changes of Alveolar Lining Fluid in Illnesses Associated with Exposure to Inhaled Non-Infectious Microbial Particles
L Teirilä, K Karvala, N Ahonen, H Riska, A Pietinalho, P Tuominen, P Piirilä, A Puustinen, H Wolff, N Palaniyar
PloS one 2014
Urological Oncology
VH Nargund, D Raghavan, HM Sandler
2014
Nano-Based PSA Biosensors: An Early Detection Technique of Prostate Cancer
MA Najeeb, S Pillai, M Chavali
Journal of Biomimetics, Biomaterials and Biomedical Engineering 2014
Aberrant PSA glycosylation—a sweet predictor of prostate cancer
S Gilgunn, PJ Conroy, R Saldova, PM Rudd, RJ O'Kennedy
Nature Reviews Urology 2013
Structural Optimization, Biological Evaluation, and Application of Peptidomimetic Prostate Specific Antigen Inhibitors
MB Kostova, DM Rosen, Y Chen, RC Mease, SR Denmeade
Journal of Medicinal Chemistry 2013
Handbook of Proteolytic Enzymes
FS Markland, S Swenson
Handbook of Proteolytic Enzymes 2013
Interaction analysis identifies semenogelin I fragments as new binding partners of PIP in human seminal plasma
AK Tomar, BS Sooch, I Raj, S Singh, S Yadav
International Journal of Biological Macromolecules 2013
PSA enzymatic activity: A new biomarker for assessing prostate cancer aggressiveness: PSA Enzymatic Activity
MJ Ahrens, PA Bertin, EF Vonesh, TJ Meade, WJ Catalona, D Georganopoulou
The Prostate 2013
Prostate specific antigen enhances the innate defence of prostatic epithelium against Escherichia coli infection: Prostate Specific Antigen and Escherichia coli Infection
CL Townes, A Ali, N Gross, D Pal, S Williamson, R Heer, CN Robson, RS Pickard, J Hall
The Prostate 2013
Enzyme Technologies: Pluripotent Players in Discovering Therapeutic Agents
T Ohshiro, H Tomoda
Enzyme Technologies: Pluripotent Players in Discovering Therapeutic Agents 2013
Comparative transcriptome analysis of the accessory sex gland and testis from the Chinese mitten crab (Eriocheir sinensis)
L He, H Jiang, D Cao, L Liu, S Hu, Q Wang
PloS one 2013
Proteolysis of complement factors iC3b and C5 by the serine protease prostate-specific antigen in prostatic fluid and seminal plasma
ML Manning, SA Williams, CA Jelinek, MB Kostova, SR Denmeade
Journal of immunology (Baltimore, Md. : 1950) 2013
Identification of a Novel Proteoform of Prostate Specific Antigen (SNP-L132I) in Clinical Samples by Multiple Reaction Monitoring
A Vegvari, K Sjodin, M Rezeli, J Malm, H Lilja, T Laurell, G Marko-Varga
Molecular & cellular proteomics : MCP 2013
Genetic Variation in KLK2 and KLK3 Is Associated with Concentrations of hK2 and PSA in Serum and Seminal Plasma in Young Men
C Savblom, C Hallden, AM Cronin, T Sall, C Savage, EA Vertosick, RJ Klein, A Giwercman, H Lilja
Clinical chemistry 2013
Correlation of Epididymal Protease Inhibitor and Fibronectin in Human Semen
X Zhang, J Fang, B Xu, S Zhang, S Su, Z Song, Y Deng, H Wang, D Zhao, X Niu, Z Wang, J Ma
PloS one 2013
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz
Protein Engineering for Therapeutics Part B 2012
Campbell-Walsh Urology
I Singh, JW Strandhoy, DG Assimos
Campbell-Walsh Urology 2012
Glycosylation of prostate specific antigen and its potential diagnostic applications
T Vermassen, MM Speeckaert, N Lumen, S Rottey, JR Delanghe
Clinica Chimica Acta 2012
Oral zinc supplementation restores high molecular weight seminal zinc binding protein to normal value in Iraqi infertile men
MH Hadwan, LA Almashhedy, AR Alsalman
BMC urology 2012
Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen
D Ulmert, MJ Evans, JP Holland, SL Rice, J Wongvipat, K Pettersson, PA Abrahamsson, PT Scardino, SM Larson, H Lilja, JS Lewis, CL Sawyers
Cancer Discovery 2012
Prostate Cancer: A Comprehensive Perspective
A Tewari
2012
Immunohistochemistry in the era of personalised medicine
CM McCourt, D Boyle, J James, M Salto-Tellez
Journal of clinical pathology 2012
Comprehensive Physiology
NE Rhaleb, XP Yang, OA Carretero
Comprehensive Physiology 2011
Advances in Clinical Chemistry
M Mahler
Advances in Clinical Chemistry Volume 54 2011
Enzymatically active prostate-specific antigen promotes growth of human prostate cancers
SA Williams, CA Jelinek, I Litvinov, RJ Cotter, JT Isaacs, SR Denmeade
The Prostate 2011
Enzymatic activity of free-prostate-specific antigen (f-PSA) is not required for some of its physiological activities
KC Chadha, BB Nair, S Chakravarthi, R Zhou, A Godoy, JL Mohler, R Aalinkeel, SA Schwartz, GJ Smith
The Prostate 2011
Circulating tumor cells in prostate cancer: A potential surrogate marker of survival
J Doyen, C Alix-Panabières, P Hofman, SK Parks, E Chamorey, H Naman, JM Hannoun-Lévi
Critical Reviews in Oncology/Hematology 2011
Substrate specificity of kallikrein-related peptidase 13 activated by salts or glycosaminoglycans and a search for natural substrate candidates
D Andrade, DM Assis, JA Santos, FM Alves, IY Hirata, MS Araujo, SI Blaber, M Blaber, MA Juliano, L Juliano
Biochimie 2011
PSA affects prostate cancer cell invasion in vitro and induces an osteoblastic phenotype in bone in vivo
AP Cumming, SN Hopmans, S Vukmirović-Popović, WC Duivenvoorden
Prostate Cancer and Prostatic Diseases 2011
Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry
Á Végvári, M Rezeli, C Sihlbom, J Häkkinen, E Carlsohn, J Malm, H Lilja, T Laurell, G Marko-Varga
Clinical Biochemistry 2011
The Discovery of Compounds That Stimulate the Activity of Kallikrein-Related Peptidase 3 (KLK3)
HH Härkönen, JM Mattsson, JA Määttä, UH Stenman, H Koistinen, S Matero, B Windshügel, A Poso, M Lahtela-Kakkonen
ChemMedChem 2011
Enzyme-mediated hydrolytic activation of prodrugs
Y Yang, H Aloysius, D Inoyama, Y Chen, L Hu
Acta Pharmaceutica Sinica B 2011
In Vitro Affinity Maturation of an Anti-PSA Antibody for Prostate Cancer Diagnostic Assay
BH Muller, A Savatier, G L'Hostis, N Costa, M Bossus, S Michel, C Ott, L Becquart, A Ruffion, EA Stura, F Ducancel
Journal of Molecular Biology 2011
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken
Advances in Cancer Research Volume 110 2011
Crystal Structure of Human Prostate-Specific Antigen in a Sandwich Antibody Complex
EA Stura, BH Muller, M Bossus, S Michel, C Jolivet-Reynaud, F Ducancel
Journal of Molecular Biology 2011
Trypsin-Like Proteolytic Contamination of Commercially Available PSAPurified From Human Seminal Fluid
ML Manning, M Kostova, SA Williams, SR Denmeade
The Prostate 2011
Prostate-specific antigen: An evolving role in diagnosis, monitoring, and treatment evaluation in prostate cancer
H Payne, P Cornford
Urologic Oncology Seminars and Original Investigations 2011
12 Kallikrein-kinin system in reproductive organs
T Monsees
Kinins 2011
Genes encoding WFDC- and Kunitz-type protease inhibitor domains: are they related?
Å Lundwall, A Clauss
Biochemical Society Transactions 2011
Tumor biomarker glycoproteins in the seminal plasma of healthy human males are endogenous ligands for DC-SIGN
GF Clark, P Grassi, PC Pang, M Panico, D Lafrenz, EZ Drobnis, MR Baldwin, HR Morris, SM Haslam, S Schedin-Weiss, W Sun, A Dell
Molecular & cellular proteomics : MCP 2011
Proteomic Analysis of Seminal Plasma from Normal Volunteers and Post-Vasectomy Patients Identifies over 2000 Proteins and Candidate Biomarkers of the Urogenital System
I Batruch, I Lecker, D Kagedan, CR Smith, BJ Mullen, E Grober, KC Lo, EP Diamandis, KA Jarvi
Journal of Proteome Research 2011
Robotic Radiosurgery. Treating Prostate Cancer and Related Genitourinary Applications
LE Ponsky, DB Fuller, RM Meier, C Ma
2011
Toxin-Based Therapeutic Approaches
A Shapira, I Benhar
Toxins 2010
Functional intersection of the kallikrein-related peptidases (KLKs) and thrombostasis axis
M Blaber, H Yoon, MA Juliano, IA Scarisbrick, SI Blaber
Biological Chemistry 2010
Prostate-specific antigen: an overlooked candidate for the targeted treatment and selective imaging of prostate cancer
AM LeBeau, M Kostova, CS Craik, SR Denmeade
Biological Chemistry 2010
Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy
SW Park, CS Kim, G Lee
Korean Journal of Urology 2010
Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia
JE Swedberg, SJ de Veer, JM Harris
Biological Chemistry 2010
Expression of semenogelins I and II and its prognostic significance in human prostate cancer
AM Canacci, K Izumi, Y Zheng, J Gordetsky, JL Yao, H Miyamoto
The Prostate 2010
Identification of prostate-specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms
A Végvári, M Rezeli, C Welinder, J Malm, H Lilja, G Marko-Varga, T Laurell
Journal of Proteomics 2010
Vitamins & Hormones
KJ Hare, FK Knop
Vitamins & Hormones 2010
On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer
CH Bangma, RH van Schaik, BG Blijenberg, MJ Roobol, H Lilja, UH Stenman
European Journal of Cancer 2010
Kallikreins on Steroids: Structure, Function, and Hormonal Regulation of Prostate-Specific Antigen and the Extended Kallikrein Locus
MG Lawrence, J Lai, JA Clements
Endocrine reviews 2010
Ovarian Cancer
MS Stack, DA Fishman
2009
Ovarian Cancer
MS Stack, DA Fishman
2009
Ovarian Cancer
MS Stack, DA Fishman
2009
Ovarian Cancer
MS Stack, DA Fishman
2009
Ovarian Cancer
MS Stack, DA Fishman
2009
Ovarian Cancer
MS Stack, DA Fishman
2009
A comprehensive resequence analysis of the KLK15–KLK3–KLK2 locus on chromosome 19q13.33
H Parikh, Z Deng, M Yeager, J Boland, C Matthews, J Jia, I Collins, A White, L Burdett, A Hutchinson, L Qi, JA Bacior, V Lonsberry, MJ Rodesch, JA Jeddeloh, TJ Albert, HA Halvensleben, TT Harkins, J Ahn, SI Berndt, N Chatterjee, R Hoover, G Thomas, DJ Hunter, RB Hayes, SJ Chanock, L Amundadottir
Human Genetics 2009
Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer
F Wiklund, SL Zheng, J Sun, HO Adami, H Lilja, FC Hsu, P Stattin, J Adolfsson, SD Cramer, D Duggan, JD Carpten, BL Chang, WB Isaacs, H Grönberg, J Xu
The Prostate 2009
Management of elevated prostate-specific antigen in men with nonbacterial chronic prostatitis
JS Sandhu
Current Urology Reports 2009
Proteomics and Comparative Genomic Investigations Reveal Heterogeneity in Evolutionary Rate of Male Reproductive Proteins in Mice (Mus domesticus)
MD Dean, NL Clark, GD Findlay, RC Karn, X Yi, WJ Swanson, MJ MacCoss, MW Nachman
Molecular Biology and Evolution 2009
Molecular insights into substrate specificity of prostate specific antigen through structural modeling
P Singh, AM LeBeau, H Lilja, SR Denmeade, JT Isaacs
Proteins: Structure, Function, and Bioinformatics 2009
Management of elevated prostate-specific antigen in men with nonbacterial chronic prostatitis
JS Sandhu
Current Prostate Reports 2009
Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA
C Sävblom, A Giwercman, J Malm, C Halldén, K Lundin, H Lilja, Y Giwercman
International Journal of Andrology 2009
Mimetics of the disulfide bridge between the N- and C-terminal cysteines of the KLK3-stimulating peptide B-2
M Pakkala, J Weisell, C Hekim, J Vepsäläinen, EA Wallen, UH Stenman, H Koistinen, A Närvänen
Amino Acids 2009
Screening for Prostate Cancer in 2008 II: The Importance of Molecular Subforms of Prostate-Specific Antigen and Tissue Kallikreins
FH Jansen, M Roobol, G Jenster, FH Schröder, CH Bangma
European Urology 2009
Complex formation between human prostate-specific antigen and protease inhibitors in mouse plasma
C Hekim, T Riipi, L Zhu, P Laakkonen, UH Stenman, H Koistinen
The Prostate 2009
Regulation of PSA secretion and survival signaling by calcium-independent phopholipase A2β in prostate cancer cells
TM Nicotera, DP Schuster, M Bourhim, K Chadha, G Klaich, DA Corral
The Prostate 2009
Optimization of peptide-based inhibitors of prostate-specific antigen (PSA) as targeted imaging agents for prostate cancer
AM LeBeau, SR Banerjee, MG Pomper, RC Mease, SR Denmeade
Bioorganic & Medicinal Chemistry 2009
Strategy for sensitive and specific detection of molecular forms of PSA based on 2DE and kinetic analysis: A step towards diagnosis of prostate cancer
V Kumar, MI Hassan, AK Singh, S Dey, TP Singh, S Yadav
Clinica Chimica Acta 2009
Sperm Biology
S Pitnick, MF Wolfner, SS Suarez
Sperm Biology 2009
Antiangiogenic properties of prostate‐specific antigen (PSA)
JM Mattsson, P Laakkonen, UH Stenman, H Koistinen
Scandinavian Journal of Clinical & Laboratory Investigation 2009
Prostate-specific antigen kallikrein and the heart
S Patanè
World journal of cardiology 2009
Prostatic specific antigen for prostate cancer detection
L Nogueira, R Corradi, JA Eastham
International braz j urol 2009
Renin Angiotensin System and Cardiovascular Disease
WC DeMello, ED Frohlich
2009
Prostate Cancer Screening
DP Ankerst, CM Tangen, IM Thompson
2009
Prostate-Specific Antigen Is a “Chymotrypsin-like” Serine Protease with Unique P1 Substrate Specificity
AM LeBeau, P Singh, JT Isaacs, SR Denmeade
Biochemistry 2009
Acoustic Whole Blood Plasmapheresis Chip for Prostate Specific Antigen Microarray Diagnostics
A Lenshof, A Ahmad-Tajudin, K Järås, AM Swärd-Nilsson, L Åberg, G Marko-Varga, J Malm, H Lilja, T Laurell
Analytical Chemistry 2009
As the World Grows: Contraception in the 21st Century
R. John Aitken, Mark A. Baker, Gustavo F. Doncel, Martin M. Matzuk, Christine K. Mauck, and Michael J. K. Harper
Journal of Clinical Investigation 2008
Configurations of a two-tiered amplified gene expression system in adenoviral vectors designed to improve the specificity of in vivo prostate cancer imaging
M Sato, ML Figueiredo, JB Burton, M Johnson, M Chen, R Powell, SS Gambhir, M Carey, L Wu
Gene Therapy 2008
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring
H Lilja, D Ulmert, AJ Vickers
Nature Reviews Cancer 2008
The influence of serial prostate-specific antigen (PSA) screening on the PSA velocity at diagnosis
NE Martin, MH Chen, WJ Catalona, S Loeb, KA Roehl, AV D'Amico
Cancer 2008
Beyond prostate-specific antigen: alternate serum markers
ML Ramírez, EC Nelson, CP Evans
Prostate Cancer and Prostatic Diseases 2008
Crystal Structure of Human Epidermal Kallikrein 7 (hK7) Synthesized Directly in its Native State in E. coli: Insights into the Atomic Basis of its Inhibition by LEKTI Domain 6 (LD6)
IS Fernández, L Ständker, HJ Mägert, WG Forssmann, G Giménez-Gallego, A Romero
Journal of Molecular Biology 2008
Human seminal proteinase and prostate-specific antigen are the same protein
A Waheed, MI Hassan, RL Etten, F Ahmad
Journal of Biosciences 2008
Proteomic profiling of the effect of prostate-specific antigen on prostate cancer cells
B Bindukumar, S Schwartz, R Aalinkeel, S Mahajan, A Lieberman, K Chadha
The Prostate 2008
Development of peptides specifically modulating the activity of KLK2 and KLK3
H Koistinen, A Närvänen, M Pakkala, C Hekim, JM Mattsson, L Zhu, P Laakkonen, UH Stenman
Biological Chemistry 2008
Prodrug Strategies in Anticancer Chemotherapy
F Kratz, IA Müller, C Ryppa, A Warnecke
ChemMedChem 2008
Evidence for the novel expression of human kallikrein-related peptidase 3, prostate-specific antigen, in the brain
JG Stone, RK Rolston, M Ueda, HG Lee, SL Richardson, RJ Castellani, G Perry, MA Smith
International journal of clinical and experimental pathology 2008
Potent and Selective Peptidyl Boronic Acid Inhibitors of the Serine Protease Prostate-Specific Antigen
AM LeBeau, P Singh, JT Isaacs, SR Denmeade
Chemistry & Biology 2008
Modified-Release Drug Delivery Technology, Second Edition
S Mitragotri, J Kost
Modified-Release Drug Delivery Technology, Second Edition 2008
PSA y hK2 en el diagnóstico de cáncer de próstata
JM Alacreu, SN Rosales, AB Alba, FE Furió, FM Martínez, JF Cruz
Actas Urológicas Españolas 2008
L’antigène spécifique de prostate : modalités d’utilisation et interprétation
JM Hannoun-Levi, A Ginot, J Thariat
Cancer/Radiothérapie 2008
Testing New PSA Subforms to Enhance the Accuracy of Predicting Cancer Risk and Disease Outcome in Prostate Cancer
H Lilja
Clinical chemistry 2008
Prostate Biopsy
JS Jones
2008
Human seminal proteinase and prostate-specific antigen are the same protein
A Waheed, I Hassan, RL Etten, F Ahmad
Journal of Biosciences 2008
Defining the extended substrate specificity of kallikrein 1-related peptidases
CA Borgoño, JA Gavigan, J Alves, B Bowles, JL Harris, G Sotiropoulou, EP Diamandis
Biological Chemistry 2007
Human tissue kallikreins as prognostic biomarkers and as potential targets for anticancer therapy
WS Chang, RH Chou, CW Wu, JY Chang
Expert Opinion on Therapeutic Patents 2007
Mechanistic insights into the inhibition of prostate specific antigen by β-lactam class compounds
P Singh, SA Williams, MH Shah, T Lectka, GJ Pritchard, JT Isaacs, SR Denmeade
Proteins: Structure, Function, and Bioinformatics 2007
Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer?
SA Williams, P Singh, JT Isaacs, SR Denmeade
The Prostate 2007
Seminal plasma albumin: origin and relation to the male reproductive parameters
S Elzanaty, J Erenpreiss, C Becker
Andrologia 2007
The Female Prostate Revisited: Perineal Ultrasound and Biochemical Studies of Female Ejaculate
F Wimpissinger, K Stifter, W Grin, W Stackl
The Journal of Sexual Medicine 2007
Structural properties of semenogelin�I
J Malm, M Jonsson, B Frohm, S Linse
FEBS Journal 2007
A locus on chromosome 20 encompassing genes that are highly expressed in the epididymis
Å Lundwall
Asian Journal of Andrology 2007
Association between Age and Epididymal and Accessory Sex Gland Function and their Relation to Sperm Motility
S Elzanaty
Systems Biology in Reproductive Medicine 2007
The Changes of Serum Prostate-specific Antigen after Ejaculation
JH Lim, SD Kim, KS Choi, SB Choi, DW Kim, JK Park
Korean Journal of Urology 2007
The GPI-anchored CD52 antigen of the sperm surface interacts with semenogelin and participates in clot formation and liquefaction of human semen
F Flori, L Ermini, GB la Sala, A Nicoli, A Capone, R Focarelli, F Rosati, CD Giovampaola
Molecular Reproduction and Development 2007
The Effect of Temperature and Standings Can Cause Deviations in Prostate Specific Antigen (PSA) Assays
CL Hsieh, CY Chang, WS Ko, BS Chen, KC Chen, RY Peng
Analytical Letters 2007
Twenty Years of PSA: From Prostate Antigen to Tumor Marker
GD Angelis, HG Rittenhouse, SD Mikolajczyk, LB Shamel, A Semjonow
Reviews in urology 2007
Crystallization and preliminary crystallographic studies of human kallikrein 7, a serine protease of the multigene kallikrein family
IS Fernández, L Ständker, WG Forssmann, G Giménez-Gallego, A Romero
Acta crystallographica. Section F, Structural biology and crystallization communications 2007
Handbook of Neurochemistry and Molecular Neurobiology
VH Routh, JJ McArdle, NM Sanders, Z Song, R Wang
Handbook of Neurochemistry and Molecular Neurobiology 2007
Measurements of Proteases or Protease System Components in Blood to Enhance Prediction of Disease Risk or Outcome in Possible Cancer
H Lilja, A Vickers, P Scardino
Journal of Clinical Oncology 2007
Long-Term Prediction of Prostate Cancer Up to 25 Years Before Diagnosis of Prostate Cancer Using Prostate Kallikreins Measured at Age 44 to 50 Years
H Lilja, D Ulmert, T Björk, C Becker, AM Serio, JÅ Nilsson, PA Abrahamsson, AJ Vickers, G Berglund
Journal of Clinical Oncology 2007
Uroonkologie
H Rübben
2007
Distribution of 15 Human Kallikreins in Tissues and Biological Fluids
JL Shaw, EP Diamandis
Clinical chemistry 2007
Seminal influences: Drosophila Acps and the molecular interplay between males and females during reproduction
KR Ram, MF Wolfner
Integrative and Comparative Biology 2007
Activation of innate immunity by prostate specific antigen (PSA)
JA Kodak, DL Mann, EN Klyushnenkova, RB Alexander
The Prostate 2006
The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition
AK Whitbread, TL Veveris-Lowe, MG Lawrence, DL Nicol, JA Clements
Biological Chemistry 2006
Fast and novel purification method to obtain the prostate specific antigen (PSA) from human seminal plasma
B Acevedo, Y Perera, E Torres, D Pentón, M Ayala, J Gavilondo
The Prostate 2006
Evolution of kallikrein-related peptidases in mammals and identification of a genetic locus encoding potential regulatory inhibitors
Å Lundwall, A Clauss, AY Olsson
Biological Chemistry 2006
The kallikrein world: an update on the human tissue kallikreins
M Paliouras, EP Diamandis
Biological Chemistry 2006
Biochemistry and Clinical Role of Trypsinogens and Pancreatic Secretory Trypsin Inhibitor
A Paju, UH Stenman
Critical Reviews in Clinical Laboratory Sciences 2006
Transrectal Sonography in Prostate Evaluation
J Boczko, E Messing, V Dogra
Radiologic Clinics of North America 2006
Évolution des formes moléculaires de l'antigène spécifique de la prostate chez des groupes sérologiques de patients atteints de pathologies prostatiques
Y Bouraoui, NB Rais, Z Elouni, C Mezigh, S Machghoul, R Oueslati
Immuno-analyse & Biologie Spécialisée 2006
Dietary γ-linolenate attenuates tumor growth in a rodent model of prostatic adenocarcinoma via suppression of elevated generation of PGE2 and 5S-HETE
H Pham, K Vang, VA Ziboh
Prostaglandins, Leukotrienes and Essential Fatty Acids 2006
Specificity Profiling of Seven Human Tissue Kallikreins Reveals Individual Subsite Preferences
M Debela, V Magdolen, N Schechter, M Valachova, F Lottspeich, CS Craik, Y Choe, W Bode, P Goettig
The Journal of biological chemistry 2006
Selective recognition of enzymatically active prostate-specific antigen (PSA) by anti-PSA monoclonal antibodies
S Michel, E Collomb-Clerc, C Geourjon, JP Charrier, J Passagot, Y Courty, G Deléage, C Jolivet-Reynaud
Journal of Molecular Recognition 2005
Ejaculates from the common marmoset (Callithrix jacchus) contain semenogelin and beta-microseminoprotein but not prostate-specific antigen
C Valtonen-Andr�, AY Olsson, PL Nayudu, Lundwall
Molecular Reproduction and Development 2005
Blood levels of free-PSA but not complex-PSA significantly correlates to prostate release of PSA in semen in young men, while blood levels of complex-PSA, but not free-PSA increase with age
C Sävblom, J Malm, A Giwercman, JÅ Nilsson, G Berglund, H Lilja
The Prostate 2005
Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues
AY Olsson, A Bjartell, H Lilja, Å Lundwall
International Journal of Cancer 2005
RM2 antigen (?1,4-GalNAc-disialyl-Lc4) as a new marker for prostate cancer
S Saito, S Egawa, M Endoh, S Ueno, A Ito, K Numahata, M Satoh, S Kuwao, S Baba, S Hakomori, Y Arai
International Journal of Cancer 2005
Adenocarcinoma of the Prostate: Epidemiological Trends, Screening, Diagnosis, and Surgical Management of Localized Disease
JC Routh, BC Leibovich
Mayo Clinic Proceedings 2005
Capillary electrophoresis for the investigation of prostate-specific antigen heterogeneity
MJ Donohue, MB Satterfield, JJ Dalluge, MJ Welch, JE Girard, DM Bunk
Analytical Biochemistry 2005
Senile seminal vesicle amyloid is derived from semenogelin I
RP Linke, R Joswig, CL Murphy, S Wang, H Zhou, U Gross, C Rocken, P Westermark, DT Weiss, A Solomon
Journal of Laboratory and Clinical Medicine 2005
Biochemical and Enzymatic Characterization of Human Kallikrein 5 (hK5), a Novel Serine Protease Potentially Involved in Cancer Progression
IP Michael, G Sotiropoulou, G Pampalakis, A Magklara, M Ghosh, G Wasney, EP Diamandis
The Journal of biological chemistry 2005
Sperm transport in the female reproductive tract
SS Suarez, AA Pacey
Human Reproduction Update 2005
Construction of tumor-specific toxins using ubiquitin fusion technique
SO Tcherniuk, J Chroboczek, MY Balakirev
Molecular Therapy 2005
Duration of sexual abstinence: epididymal and accessory sex gland secretions and their relationship to sperm motility
S Elzanaty, J Malm, A Giwercman
Human Reproduction 2005
Cancer Chemoprevention
GJ Kelloff, ET Hawk, CC Sigman
2005
Characterization of Novel Monoclonal Antibodies for Prostate-Specific Antigen (PSA) with Potency to Recognize PSA Bound to α2-Macroglobulin
Y Baumgart, A Otto, A Schäfer, E Usbeck, C Cott, A Schott, M Tornack, A Wenzel, A Mossie, G Birkenmeier
Clinical chemistry 2005
The Rab27a-binding protein, JFC1, regulates androgen-dependent secretion of prostate-specific antigen and prostatic-specific acid phosphatase1
JL Johnson, BA Ellis, D Noack, MC Seabra, SD Catz
Biochemical Journal 2005
Visco-elasticity of seminal fluid in relation to the epididymal and accessory sex gland function and its impact on sperm motility
S ELzanaty, J Malm, A Giwercman
International Journal of Andrology 2004
The role of prostate-specific antigen in the clinical evaluation of prostatic disease
SR Denmeade, JT Isaacs
BJU International 2004
The emerging roles of human tissue kallikreins in cancer
CA Borgoño, EP Diamandis
Nature Reviews Cancer 2004
Taxon-specific evolution of glandular kallikrein genes and identification of a progenitor of prostate-specific antigen
AY Olsson, H Lilja, Å Lundwall
Genomics 2004
Production of Monoclonal and Polyclonal Antibodies against Prostate-Specific Antigen, a Prostate Cancer Serum Marker
SF Chou, CY Chen
Hybridoma and Hybridomics 2004
The evolution of the glandular kallikrein locus: identification of orthologs and pseudogenes in the cotton-top tamarin
AY Olsson, C Valtonen-André, H Lilja, Å Lundwall
Gene 2004
Prostate-specific antigen and screening for prostate cancer
M Han, PH Gann, WJ Catalona
Medical Clinics of North America 2004
Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells
Y Fujii, S Kawakami, Y Okada, Y Kageyama, K Kihara
American journal of physiology. Endocrinology and metabolism 2004
Androgen Receptor in Prostate Cancer
CA Heinlein, C Chang
Endocrine reviews 2004
Cancer Diagnostics
RM Nakamura, WW Grody, JT Wu, RB Nagle
2004
Isoformen des freien prostataspezifischen Antigens
A Haese, J Noldus, T Steuber, H Huland, H Lilja
Der Urologe, Ausgabe A 2004
Prostate-specific antigen (PSA) protein does not affect growth of prostate cancer cells in vitro or prostate cancer xenografts in vivo
SR Denmeade, I Litvinov, LJ Sokoll, H Lilja, JT Isaacs
The Prostate 2003
Human tissue kallikreins and testicular cancer
LY Luos, G Yousef, EP Diamandis
APMIS 2003
Distribution and secretory pathways of prostate specific antigen, alpha1-antichymotrypsin and prostate secretory granules in prostate cancers
E Ishida, M Nakamura, K Shimada, M Kishi, S Nakaoka, N Konishi
Pathology International 2003
Complex alternative splicing of the hKLK3 gene coding for the tumor marker PSA (prostate-specific-antigen)
N Heuz��-Vourc'h, V Leblond, Y Courty
European Journal of Biochemistry 2003
Prostate Specific Antigen and Human Glandular Kallikrein 2 in Early Detection of Prostate Cancer
G Karazanashvili, PA Abrahamsson
The Journal of Urology 2003
Prostate Cancer
WG Nelson, AM de Marzo, WB Isaacs
New England Journal of Medicine 2003
Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infection
B Zackrisson, P Ulleryd, G Aus, H Lilja, T Sandberg, J Hugosson
Urology 2003
Role of kallikrein enzymes in the central nervous system
GM Yousef, T Kishi, EP Diamandis
Clinica Chimica Acta 2003
Quantification of Seminal Plasma Motility Inhibitor/Semenogelin in Human Seminal Plasma
K Yoshida, T Yamasaki, M Yoshiike, S Takano, I Sato, T Iwamoto
Journal of andrology 2003
Assisted Ejaculation and Semen Characteristics in Spinal Cord Injured Males
J Snksen
Scandinavian Journal of Urology and Nephrology 2003
Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line
JJ Christiansen, SA Rajasekaran, P Moy, A Butch, L Goodglick, Z Gu, RE Reiter, NH Bander, AK Rajasekaran
The Prostate 2003
Three immunoassays based on monoclonal antibodies specific for prostate specific antigen (PSA), ?-1-antichymotrypsin (ACT), and the PSA-ACT complex
XS Wan, YA Xu, JH Ware, AR Kennedy
The Prostate 2003
Single Nucleotide Polymorphism of the Human Kallikrein-2 Gene Highly Correlates With Serum Human Kallikrein-2 Levels and in Combination Enhances Prostate Cancer Detection
RK Nam, WW Zhang, J Trachtenberg, E Diamandis, A Toi, M Emami, M Ho, J Sweet, A Evans, MA Jewett, SA Narod
Journal of Clinical Oncology 2003
Molecular Cloning of Complementary DNA Encoding Mouse Seminal Vesicle-Secreted Protein SVS I and Demonstration of Homology with Copper Amine Oxidases1
Å Lundwall, J Malm, A Clauss, C Valtonen-André, AY Olsson
Biology of reproduction 2003
Surgical Oncology
TJ Saclarides, KW Millikan, CV Godellas
Surgical Oncology 2003
Reduced Polymorphism in the Chimpanzee Semen Coagulating Protein, Semenogelin I
SB Kingan, M Tatar, DM Rand
Journal of Molecular Evolution 2003
Discrimination of Benign From Malignant Prostatic Disease by Selective Measurements of Single Chain, Intact Free Prostate Specific Antigen
T Steuber, P Nurmikko, A Haese, K Pettersson, M Graefen, P Hammerer, H Huland, H Lilja
The Journal of Urology 2002
Prostate-specific antigen: a diagnostic marker and a tool for targeted delivery of drugs to prostate tumours
HS Basu, B Frydman
Expert Opinion on Therapeutic Patents 2002
Pharmacotherapy for biochemical recurrences after therapy for localised prostate cancer
DK Ornstein, KE Gaston
Expert Opinion on Pharmacotherapy 2002
Human Tissue Kallikreins: A New Enzymatic Cascade Pathway?
GM Yousef, EP Diamandis
Biological Chemistry 2002
Allogeneic whole-cell vaccine: a phase I/II study in men with hormone-refractory prostate cancer
JD Eaton, MJ Perry, S Nicholson, M Guckian, N Russell, M Whelan, RS Kirby
BJU International 2002
Amidolytic activity of prostatic acid phosphatase on human semenogelins and semenogelin-derived synthetic substrates
M Brillard-Bourdet, S Réhault, L Juliano, M Ferrer, T Moreau, F Gauthier
European Journal of Biochemistry 2002
Improving the utility of prostate specific antigen (PSA) in the diagnosis of prostate cancer: the use of PSA derivatives and novel markers
S Jain, AG Bhojwani, JK Mellon
Postgraduate medical journal 2002
A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein
A Clauss, H Lilja, A Lundwall
Biochemical Journal 2002
C-terminal domain of rodent intestinal mucin Muc3 is proteolytically cleaved in the endoplasmic reticulum to generate extracellular and membrane components
R Wang, IA Khatri, JF Forstner
Biochemical Journal 2002
Design of new and sensitive fluorogenic substrates for human kallikrein hK3 (prostate-specific antigen) derived from semenogelin sequences
S Réhault, M Brillard-Bourdet, L Bourgeois, G Frenette, L Juliano, F Gauthier, T Moreau
Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 2002
Organization and evolution of the glandular kallikrein locus in Mus musculus
AY Olsson, Å Lundwall
Biochemical and Biophysical Research Communications 2002
Pilot Study: A Non-Invasive Urine Test for Potential Prostate Abnormalities
HH Cohly, MS Koelle, MF Angel, SK Das, WB Shingleton
International journal of molecular sciences 2002
Monoclonal Antibodies, Immunofluorometric Assay, and Detection of Human Semenogelin in Male Reproductive Tract: No Association with In Vitro Fertilizing Capacity of Sperm1
H Koistinen, T Soini, J Leinonen, C Hyden-Granskog, J Salo, M Halttunen, UH Stenman, M Seppälä, R Koistinen
Biology of reproduction 2002
Effects of the Bowman-Birk inhibitor on growth, invasion, and clonogenic survival of human prostate epithelial cells and prostate cancer cells
AR Kennedy, XS Wan
The Prostate 2002
Human Tissue Kallikreins: A Family of New Cancer Biomarkers
EP Diamandis, GM Yousef
Clinical chemistry 2002
Design and Synthesis of a Pro-Drug of Vinblastine Targeted at Treatment of Prostate Cancer with Enhanced Efficacy and Reduced Systemic Toxicity
SF Brady, JM Pawluczyk, PK Lumma, DM Feng, JM Wai, R Jones, D DeFeo-Jones, BK Wong, C Miller-Stein, JH Lin, A Oliff, RM Freidinger, VM Garsky
Journal of Medicinal Chemistry 2002
The Expanded Human Kallikrein (KLK) Gene Family: Genomic Organisation, Tissue-Specific Expression and Potential Functions
J Clements, J Hooper, Y Dong, T Harvey
Biological Chemistry 2001
Comparison of human prostate specific glandular kallikrein 2 and prostate specific antigen gene expression in prostate with gene amplification and overexpression of prostate specific glandular kallikrein 2 in tumor tissue
AM Herrala, KS Porvari, AP Kyll�nen, PT Vihko
Cancer 2001
Involvement of the C-terminal end of the prostrate-specific antigen in a conformational epitope: characterization by proteolytic degradation of monoclonal antibody-bound antigen and mass spectrometry
S Michel, E Forest, Y P�tillot, G Del�age, N Heuz�-Vourc'h, Y Courty, D Lascoux, M Jolivet, C Jolivet-Reynaud
Journal of Molecular Recognition 2001
MOLECULAR GENETIC PROFILING OF GLEASON GRADE 4/5 PROSTATE CANCERS COMPARED TO BENIGN PROSTATIC HYPERPLASIA
TA Stamey, JA Warrington, MC Caldwell, Z Chen, Z Fan, M Mahadevappa, JO McNEAL, R Nolley, Z Zhang
The Journal of Urology 2001
Characterization of PSA-RP2, a protein related to prostate-specific antigen and encoded by alternative hKLK3 transcripts
N Heuz��-Vourc'H, V Leblond, S Olayat, F Gauthier, Y Courty
European Journal of Biochemistry 2001
Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3
S R������hault, P Monget, S Mazerbourg, R Tremblay, N Gutman, F Gauthier, T Moreau
European Journal of Biochemistry 2001
Expression, purification, and characterization of active recombinant prostate-specific antigen inPichia pastoris (yeast)
LL Habeck, RM Belagaje, GW Becker, JE Hale, LM Churgay, M Ulmer, XY Yang, KA Shackelford, JM Richardson, MG Johnson, LG Mendelsohn
The Prostate 2001
The biosynthesis of prostate-specific antigen in non prostatic cell lines
A Waheed, RL van Etten
Clinical Biochemistry 2001
Separation methods applicable to prostate cancer diagnosis and monitoring therapy
S Sumi, K Arai, K Yoshida
Journal of Chromatography B Biomedical Sciences and Applications 2001
The Role of Molecular Forms of Prostate-Specific Antigen (PSA or hK3) and of Human Glandular Kallikrein 2 (hK2) in the Diagnosis and Monitoring of Prostate Cancer and in Extra-Prostatic Disease
C Becker, J Noldus, E Diamandis, H Lilja
Critical Reviews in Clinical Laboratory Sciences 2001
Semenogelin II Gene Is Replaced by a Truncated LINE1 Repeat in the Cotton-Top Tamarin1
Å Lundwall, AY Olsson
Biology of reproduction 2001
Detection and cloning of a protein recognized by anti-human prostate-specific antigen (PSA) antibody in the rat ventral prostate
M Onozawa, K Fukuda, M Watanabe, M Ohtani, H Akaza, T Sugimura, K Wakabayashi
Japanese journal of cancer research : Gann 2001
The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease*
GM Yousef, EP Diamandis
Endocrine reviews 2001
Peptides: The Wave of the Future: Proceedings of the Second International and the Seventeenth American Peptide Symposium, June 9–14, 2001, San Diego, California, U.S.A
M Lebl, RA Houghten
2001
Discrimination of Prostate Cancer from Benign Disease by Plasma Measurement of Intact, Free Prostate-specific Antigen Lacking an Internal Cleavage Site at Lys145-Lys146
P Nurmikko, K Pettersson, T Piironen, J Hugosson, H Lilja
Clinical chemistry 2001
Characterization of hK4 (Prostase), a Prostate-Specific Serine Protease: Activation of the Precursor of Prostate Specific Antigen (pro-PSA) and Single-Chain Urokinase-Type Plasminogen Activator and Degradation of Prostatic Acid Phosphatase
TK Takayama, BA McMullen, PS Nelson, M Matsumura, K Fujikawa
Biochemistry 2001
Modulation of Recombinant Human Prostate-Specific Antigen: Activation by Hofmeister Salts and Inhibition by Azapeptides Appendix: Thermodynamic Interpretation of the Activation by Concentrated Salts
X Huang, CT Knoell, G Frey, M Hazegh-Azam, AH Tashjian, L Hedstrom, RH Abeles, SN Timasheff
Biochemistry 2001
The Synthesis of a Prodrug of Doxorubicin Designed to Provide Reduced Systemic Toxicity and Greater Target Efficacy
VM Garsky, PK Lumma, DM Feng, J Wai, HG Ramjit, MK Sardana, A Oliff, RE Jones, D DeFeo-Jones, RM Freidinger
Journal of Medicinal Chemistry 2001
Activation of Prostate-Specific Antigen Precursor (pro-PSA) by Prostin, a Novel Human Prostatic Serine Protease Identified by Degenerate PCR ,
TK Takayama, CA Carter, T Deng
Biochemistry 2001
Changes in prostate-specific antigen (PSA) level correlate with growth inhibition of prostate cancer cells treated in vitro with a novel anticancer drug, irofulven
A L Woynarowska BAHigdon, R M Muñoz, P Bushong, S J Waters
Investigational New Drugs 2001
Detection and Cloning of a Protein Recognized by Anti‐human Prostate‐specific Antigen (PSA) Antibody in the Rat Ventral Prostate
Onozawa M, Fukuda K, Watanabe M, Ohtani M, Akaza H, Sugimura T, Wakabayashi K
Japanese journal of cancer research : Gann 2001
The role of free prostate-specific antigen in prostate cancer detection
M Han, SR Potter, AW Partin
Current Urology Reports 2000
Report on Prostate Cancer Tumor Marker Workshop 1999
AW Partin, GP Murphy, MK Brawer
Cancer 2000
DISCRIMINATION OF MEN WITH PROSTATE CANCER FROM THOSE WITH BENIGN DISEASE BY MEASUREMENTS OF HUMAN GLANDULAR KALLIKREIN 2 (HK2) IN SERUM
C Becker, T Piironen, K Pettersson, TH BJöRK, KJ Wojno, JE Oesterling, H Lilja
The Journal of Urology 2000
A dual-monoclonal sandwich assay for prostate-specific membrane antigen: Levels in tissues, seminal fluid and urine
RL Sokoloff, KC Norton, CL Gasior, KM Marker, LS Grauer
The Prostate 2000
Different proportions of various prostate-specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells
A Kumar, SD Mikolajczyk, TM Hill, LS Millar, MS Saedi
The Prostate 2000
Expression and Characterization of Trypsinogen Produced in the Human Male Genital Tract
A Paju, A Bjartell, WM Zhang, S Nordling, A Borgström, J Hansson, UH Stenman
The American Journal of Pathology 2000
Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomy
SF Shariat, F Bergamaschi, HL Adler, C Nguyen, MW Kattan, TM Wheeler, KM Slawin
Urology 2000
Prostate-specific antigen and other prostate cancer markers
UH Stenman, P Finne, WM Zhang, J Leinonen
Urology 2000
ELISA for a complexed antigen with a monoclonal antibody blocking reaction with the free antigen—assay-specific for complexed prostate-specific antigen
K Matsumoto, N Konishi, T Samori, E Kimura, M Doi, S Kato, Y Yuki
Journal of Immunological Methods 2000
THE PROSTATE: DEVELOPMENT AND PHYSIOLOGY
SW Hayward, GR Cunha
Radiologic Clinics of North America 2000
Expression, Purification, and Characterization of Deglycosylated Human Pro-Prostate-Specific Antigen
KK Bowman, J Clark, L Yu, K Mortara, K Radika, J Wang, H Zhan
Protein Expression and Purification 2000
A peptide–doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo
D DeFeo-Jones, VM Garsky, BK Wong, DM Feng, T Bolyar, K Haskell, DM Kiefer, K Leander, E McAvoy, P Lumma, J Wai, ET Senderak, SL Motzel, K Keenan, MV Zwieten, JH Lin, R Freidinger, J Huff, A Oliff, RE Jones
Nature Medicine 2000
Regions of Prostate-specific Antigen (PSA) Promoter Confer Androgen-independent Expression of PSA in Prostate Cancer Cells
F Yeung, X Li, J Ellett, J Trapman, C Kao, LW Chung
The Journal of biological chemistry 2000
Serum Human Glandular Kallikrein-2 Protease Levels Predict the Presence of Prostate Cancer Among Men With Elevated Prostate-Specific Antigen
RK Nam, EP Diamandis, A Toi, J Trachtenberg, A Magklara, A Scorilas, PA Papnastasiou, MA Jewett, SA Narod
Journal of Clinical Oncology 2000
Sensitive and Specific Immunodetection of Human Glandular Kallikrein 2 in Serum
C Becker, T Piironen, J Kiviniemi, H Lilja, K Pettersson
Clinical chemistry 2000
DIFFERENT MOLECULAR FORMS OF UNCOMPLEXED PROSTATE SPECIFIC ANTIGEN (PSA) SHOW SIMILAR IMMUNOREACTIVITIES
LF Chu, Z Chen, TA Stamey
The Journal of Urology 1999
SIGNIFICANCE AND METABOLISM OF COMPLEXED AND NONCOMPLEXED PROSTATE SPECIFIC ANTIGEN FORMS, AND HUMAN GLANDULAR KALLIKREIN 2 IN CLINICALLY LOCALIZED PROSTATE CANCER BEFORE AND AFTER RADICAL PROSTATECTOMY
H Lilja, A Haese, T Björk, MG Friedrich, T Piironen, K Pettersson, E Huland, H Huland
The Journal of Urology 1999
Treatment with soybean-derived Bowman Birk inhibitor increases serum prostate-specific antigen concentration while suppressing growth of human prostate cancer xenografts in nude mice
XS Wan, JH Ware, L Zhang, PM Newberne, SM Evans, LC Clark, AR Kennedy
The Prostate 1999
Localization of prostate-specific antigen-like immunoreactivity in human salivary gland and salivary gland tumors
K Tazawa, Y Kurihara, S Kamoshida, K Tsukada, Y Tsutsumi
Pathology International 1999
Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors
J Lovgren, K Airas, H Lilja
European Journal of Biochemistry 1999
New World, but not Old World, monkeys carry several genes encoding beta-microseminoprotein
M Makinen, C Valtonen-Andre, A Lundwall
European Journal of Biochemistry 1999
REVERSE ZYMOGRAPHY STUDIES OF PROTEASE INHIBITORS IN THE SECRETIONS OF DIFFERENT LOBES OF RAT PROSTATE
MJ Wilson
Systems Biology in Reproductive Medicine 1999
Prostate-specific antigen
UH Stenman, J Leinonen, WM Zhang, P Finne
Seminars in Cancer Biology 1999
cDNA, Genomic Cloning, and Gene Expression Analysis of Mouse PSP94 (Prostate Secretory Protein of 94 Amino Acids)
JW Xuan, J Kwong, FL Chan, M Ricci, Y Imasato, H Sakai, GH Fong, C Panchal, JL Chin
DNA and Cell Biology 1999
CLEARANCE MECHANISM OF PROSTATE SPECIFIC ANTIGEN AND ITS COMPLEXES WITH alpha 2-MACROGLOBULIN AND alpha 1-ANTICHYMOTRYPSIN
G Birkenmeier, F Struck, R Gebhardt
The Journal of Urology 1999
Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer
JA Foekens, EP Diamandis, H Yu, MP Look, ME Gelder, WL van Putten, JG Klijn
British Journal of Cancer 1999
Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention
X Zi, R Agarwal
Proceedings of the National Academy of Sciences 1999
Seminal plasma biochemical markers and their association with semen analysis findings
EP Diamandis, WP Arnett, G Foussias, H Pappas, S Ghandi, DN Melegos, B Mullen, H Yu, J Srigley, K Jarvi
Urology 1999
Advances in Oncobiology
DL Miller, FG Kern
Advances in Oncobiology 1999
Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: Implications for prostate cancer intervention
X Zi, R Agarwal
Proceedings of the National Academy of Sciences 1999
The cleavage site specificity of human prostate specific antigen for insulin-like growth factor binding protein-3
E Okabe, J Kajihara, Y Usami, K Hirano
FEBS Letters 1999
Localization of a New Prostate-specific Antigen-related Serine Protease Gene, KLK4 , Is Evidence for an Expanded Human Kallikrein Gene Family Cluster on Chromosome 19q13.3–13.4
SA Stephenson, K Verity, LK Ashworth, JA Clements
The Journal of biological chemistry 1999
Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group
GJ Bubley, M Carducci, W Dahut, N Dawson, D Daliani, M Eisenberger, WD Figg, B Freidlin, S Halabi, G Hudes, M Hussain, R Kaplan, C Myers, W Oh, DP Petrylak, E Reed, B Roth, O Sartor, H Scher, J Simons, V Sinibaldi, EJ Small, MR Smith, DL Trump, R Vollmer, G Wilding
Journal of Clinical Oncology 1999
The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines
S Majumdar, EP Diamandis
British Journal of Cancer 1999
Time-resolved fluorescence in immunocytochemical detection of prostate-specific antigen in prostatic tissue sections
A Bjartell, S Laine, K Pettersson, E Nilsson, T Lövgren, H Lilja
The Histochemical Journal 1999
Equivalent recognition of free and act-complexed PSA in a monoclonal-polyclonal sandwich assay is conferred by binding specificity of the monoclonal antibody
Z Zhou, EG Armstrong, A Belenky, JV Freeman, KK Yeung
Journal of Clinical Laboratory Analysis 1998
PROSTATE-SPECIFIC ANTIGEN FORMS COMPLEXES WITH HUMAN alpha 2-MACROGLOBULIN AND BINDS TO THE alpha 2-MACROGLOBULIN RECEPTOR/LDL RECEPTOR-RELATED PROTEIN
A Otto, J Bar, G Birkenmeier
The Journal of Urology 1998
DEVELOPMENT OF PROSTATE-SPECIFIC ANTIGEN PROMOTER-BASED GENE THERAPY FOR ANDROGEN-INDEPENDENT HUMAN PROSTATE CANCER
A Gotoh, SC Ko, T Shirakawa, J Cheon, C Kao, T Miyamoto, TA Gardner, LJ Ho, CB Cleutjens, J Trapman, FL Graham, LW Chung
The Journal of Urology 1998
MONOCLONAL ANTIBODIES 2F5 AND 4G10 AGAINST PROSTATE SPECIFIC ANTIGEN (PSA) COMPLEXED TO alpha 1-ANTICHYMOTRYPSIN
Z Chen, H Chen, TA Stamey
The Journal of Urology 1998
Cloning and characterization of the α1-antichymotrypsin produced by human prostate tissue
G Wu, H Lilja, AT Cockett, S Gershagen
The Prostate 1998
Prostate-Specific Antigen and New Related Markers for Prostate Cancer
R Daher, M Beaini
Clinical Chemistry and Laboratory Medicine 1998
Binding of seminal vesicle proteins to the plasma membrane of rat spermatozoa in vivo and in vitro
CARBALLADA, ESPONDA
International Journal of Andrology 1998
The release of free prostate specific antigen into the circulation during transurethral resection of the prostate: kinetics and interaction with serum protease inhibitors
Coker, Coptcoat, Mulvin, Cuomo, Scott, Sherwood
BJU International 1998
STABILITY OF FREE AND TOTAL PROSTATE SPECIFIC ANTIGEN IN SERUM FROM PATIENTS WITH PROSTATE CARCINOMA AND BENIGN HYPERPLASIA
E Paus, O Nilsson, OP Bormer, SD Fossa, B Otnes, E Skovlund
The Journal of Urology 1998
Hypertension
P Hamet, Z Pausova, V Adarichev, K Adaricheva, J Tremblay
Journal of Hypertension 1998
Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours
RE Hall, JA Clements, SN Birrell, WD Tilley
British Journal of Cancer 1998
Understanding artificial neural networks and exploring their potential applications for the practicing urologist
JT Wei, Z Zhang, SD Barnhill, KR Madyastha, H Zhang, JE Oesterling
Urology 1998
Percent free prostate-specific antigen: the next frontier in prostate-specific antigen testing
MC Beduschi, JE Oesterling
Urology 1998
Structural Characterization and Mapping of the Normal Epithelial Cell-Specific 1 Gene
L Luo, JA Herbrick, SW Scherer, B Beatty, J Squire, EP Diamandis
Biochemical and Biophysical Research Communications 1998
Human Kallikrein 2 (hK2) and Prostate-Specific Antigen (PSA): Two Closely Related, but Distinct, Kallikreins in the Prostate
HG Rittenhouse, JA Finlay, SD Mikolajczyk, AW Partin
Critical Reviews in Clinical Laboratory Sciences 1998
Broadsheet number 42: Prostate specific antigen update
KA Sikaris, M Meerkin, MD Guerin
Pathology 1998
An audit of prostate-specific antigen and clinical symptoms in general practice
S Ramachandran, MC Foster, DR Thomas, AK Roalfe, RA Hall
Postgraduate medical journal 1998
Bayer Immuno 1 PSA Assay: an automated, ultrasensitive method to quantitate total PSA in serum
D L Morris, P W Dillon, D L Very, P Ng, L Kish, J L Goldblatt, D J Bruzek, D W Chan, M S Ahmed, D Witek, H A Fritsche, C Smith, D Schwartz, M K Schwartz, J L Noteboom, R L Vessella, K K Yeung, W J Allard
Journal of Clinical Laboratory Analysis 1998
PSA Concentrations in Seminal Plasma
TJ Wang, HG Rittenhouse, RL Wolfert, CM Lynne, NL Brackett
Clinical chemistry 1998
Equivalent recognition of free and act‐complexed PSA in a monoclonal‐polyclonal sandwich assay is conferred by binding specificity of the monoclonal antibody
Zhou Z, Armstrong EG, Belenky A, Freeman JV, Yeung KK
Journal of Clinical Laboratory Analysis 1998
Bayer immuno 1™ PSA assay: An automated, ultrasensitive method to quantitate total PSA in serum
Morris DL, Dillon PW, Very DL, Ng P, Kish L, Goldblatt JL, Bruzek DJ, Chan DW, Ahmed MS, Witek D, Fritsche HA, Smith C, Schwartz D, Schwartz MK, Noteboom JL, Vessella RL, Yeung KK, Allard WJ
Journal of Clinical Laboratory Analysis 1998
Frequent detection of mutations in the 5' flanking region of the prostate-specific antigen gene in female breast cancer
D Tsuyuki, L Grass, EP Diamandis
European Journal of Cancer 1997
Chemical Characterization of the Predominant Proteins Secreted by Mouse Seminal Vesicles
Lundwall, A Peter, J Lovgren, H Lilja, J Malm
European Journal of Biochemistry 1997
Ala217 is Important for the Catalytic Function and Autoactivation of Prostate-Specific Human Kallikrein 2
SD Mikolajczyk, LS Millar, KM Marker, LS Grauer, A Goel, MM Cass, A Kumar, MS Saedi
European Journal of Biochemistry 1997
The Influence of Ejaculation on Serum Levels of Prostate Specific Antigen
A Heidenreich, R Vorreuther, S Neubauer, J Westphal, UH Engelmann, JW Moul
The Journal of Urology 1997
ISOLATION AND CHARACTERIZATION OF FREE FORM PROSTATE SPECIFIC ANTIGEN (f-PSA) IN SERA OF MEN WITH PROSTATE CANCER
J Noldus, Z Chen, TA Stamey
The Journal of Urology 1997
Molecular Staging of Prostate Cancer. III. Effects of Cystoscopy and Needle Biopsy on the Enhanced Reverse Transcriptase Polymerase Chain Reaction Assay
C Cama, CA Olsson, R Buttyan, GM de Vries, GJ Wise, AE Katz
The Journal of Urology 1997
Prostate-specific antigen forms a complex with and cleaves α1-protease inhibitor in vitro
WM Zhang, J Leinonen, N Kalkkinen, UH Stenman
The Prostate 1997
Diagnostic and prognostic markers for human prostate cancer
X Gao, AT Porter, DJ Grignon, JE Pontes, KV Honn
The Prostate 1997
Characterization of residual tumor cells following radical radiation therapy for prostatic adenocarcinoma; Immunohistochemical expression of prostate-specific antigen, prostatic acid phosphatase, and cytokeratin 8
G Ljung, M Norberg, L Holmberg, C Busch, S Nilsson
The Prostate 1997
Molecular Cloning and Gene Expression Analysis of PSP94 (Prostate Secretory Protein of 94 Amino Acids) in Primates
JW Xuan, D Wu, Y Guo, S Garde, DT Shum, M Mbikay, R Zhong, JL Chin
DNA and Cell Biology 1997
Effect of Transurethral Microwave Thermotherapy on Serum Concentrations of Total and Free Prostate-specific Antigen
M Waldén, C Dahlstrand, S Petersson, GÖ Lindstedt
Scandinavian Journal of Urology and Nephrology 1997
Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA
O Nilsson, A Peter, I Andersson, K Nilsson, B Grundström, B Karlsson
British Journal of Cancer 1997
Individual prostate-specific antigen (PSA) forms as prostate tumor markers
C Becker, H Lilja
Clinica Chimica Acta 1997
MOLECULAR FORMS OF SERUM PROSTATE-SPECIFIC ANTIGEN
PA Abrahamsson, H Lilja, JE Oesterling
Urologic Clinics of North America 1997
PROSTATE-SPECIFIC ANTIGEN
LJ Sokoll, DW Chan
Urologic Clinics of North America 1997
Lantigène spécifique de la prostate (PSA)
M Toubert
Immuno-analyse & Biologie Spécialisée 1997
The Kinin System
A Schmaier
The Kinin System 1997
Purification and characterization of prostate specific antigen from human urine
K Shibata, J Kajihara, K Kato, K Hirano
Biochimica et Biophysica Acta (BBA) - General Subjects 1997
Activation of the Zymogen Form of Prostate-Specific Antigen by Human Glandular Kallikrein 2
J Lövgren, K Rajakoski, M Karp, Å Lundwall, H Lilja
Biochemical and Biophysical Research Communications 1997
Proteolytic Activity in the Seminal Plasma of the Mud Crab, Scylla serrata (Forskal)
V Jayasankar, T Subramoniam
Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 1997
Prostate-specific antigen: molecular forms and the human kallikrein gene family
H Lilja
British Journal of Urology 1997
New diagnostic applications of prostate-specific antigen
E Diamandis
British Journal of Urology 1997
Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen
SR Denmeade, W Lou, J Lövgren, J Malm, H Lilja, JT Isaacs
Cancer research 1997
Specific and Efficient Peptide Substrates for Assaying the Proteolytic Activity of Prostate-specific Antigen1
SR Denmeade, W Lou, J Lövgren, J Malm, H Lilja, JT Isaacs
Cancer research 1997
Characterization of the Precursor of Prostate-specific Antigen: ACTIVATION BY TRYPSIN AND BY HUMAN GLANDULAR KALLIKREIN
TK Takayama, K Fujikawa, EW Davie
The Journal of biological chemistry 1997
Purification of enzymatically active kallikrein hK2 from human seminal plasma
G Frenette, D Deperthes, RR Tremblay, C Lazure, JY Dubé
Biochimica et Biophysica Acta (BBA) - General Subjects 1997
Serpin-derived Peptide Substrates for Investigating the Substrate Specificity of Human Tissue Kallikreins hK1 and hK2
L Bourgeois, M Brillard-Bourdet, D Deperthes, MA Juliano, L Juliano, RR Tremblay, JY Dubé, F Gauthier
The Journal of biological chemistry 1997
The ratio of free to total serum prostate specific antigen and its use in differential diagnosis of prostate carcinoma in japan
S Egawa, S Soh, M Ohori, T Uchida, K Gohji, A Fujii, S Kuwao, K Koshiba
Cancer 1997
Chemistry and Biology of Serpins
FC Church, DD Cunningham, D Ginsburg, M Hoffman, SR Stone, DM Tollefsen
1997
Two-dimensional gel electrophoresis detects prostate-specific antigen–α1-antichymotrypsin complex in serum but not in prostatic fluid
Y Qian, JA Sensibar, DJ Zelner, AJ Schaeffer, JA Finlay, HG Rittenhouse, C Lee
Clinical chemistry 1997
Human prostate-specific glandular kallikrein is expressed as an active and an inactive protein
A Herrala, R Kurkela, K Porvari, R Isomäki, P Henttu, P Vihko
Clinical chemistry 1997
Prostate-specific antigen in serum during the menstrual cycle
N Zarghami, L Grass, ER Sauter, EP Diamandis
Clinical chemistry 1997
Characterization of Prostate-Specific Antigen Proteolytic Activity on its Major Physiological Substrate, the Sperm Motility Inhibitor Precursor/Semenogelin I
M Robert, BF Gibbs, E Jacobson, C Gagnon
Biochemistry 1997
Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue
H Yu, EP Diamandis, M Levesque, M Giai, R Roagna, R Ponzone, P Sismondi, M Monne, CM Croce
Breast Cancer Research and Treatment 1996
Isolation and Characterization of the Major Gel Proteins in Human Semen, Semenogen I and Semenogen II
J Malm, J Hellman, H Magnusson, CB Laurell, H Lilja
European Journal of Biochemistry 1996
Characterization of Semenogelin II and its Molecular interaction with Prostate-Specific Antigen and Protein C Inhibitor
H Kise, J Nishioka, J Kawamura, K Suzuki
European Journal of Biochemistry 1996
In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines
MH Sokoloff, CL Tso, R Kaboo, S Taneja, S Pang, JB deKernion, AS Belldegrun
Cancer 1996
Prostate Specific Antigen Releases a Kinin-Like Substance on Proteolysis of Seminal Vesicle Fluid that Stimulates Smooth Muscle Contraction
J Fichtner, HC Graves, K Thatcher, C Yemoto, LM Shortlife
The Journal of Urology 1996
Complex Formation Between PSA Isoenzymes and Protease Inhibitors
J Leinonen, WM Zhang, UH Stenman
The Journal of Urology 1996
Addition of Purified Prostate Specific Antigen to Serum from Female Subjects
Z Chen, K Komatsu, A Prestigiacomo, TA Stamey
The Journal of Urology 1996
Technicon Immuno 1® PSA assay measures both free and alpha-1-antichymotrypsin-complexed prostate-specific antigen on an equimolar basis
Z Zhou, PC Ng, DL Very, WJ Allard, KK Yeung
Journal of Clinical Laboratory Analysis 1996
Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer
CY Young, T Seay, K Hogen, MC Charlesworth, PC Roche, GG Klee, DJ Tindall
The Prostate 1996
Dual monoclonal antibody immunoassay for free prostate-specific antigen
TJ Wang, TM Hill, RL Sokoloff, F Frankenne, HG Rittenhouse, RL Wolfert
The Prostate 1996
The role of prostate-specific antigen in the chemoprevention of prostate cancer
ED Crawford, EP DeAntoni, CA Ross
Journal of Cellular Biochemistry 1996
Prostate Cancer Old Problems and New Approaches
KV Honn, A Aref, YQ Chen, ML Cher, JD Crissman, JD Forman, X Gao, D Grignon, M Hussain, AT Porter, JE Pontes, I Powell, B Redman, W Sakr, R Severson, DG Tang, DP Wood
Pathology & Oncology Research 1996
Addition of Purified Prostate Specific Antigen to Serum from Female Subjects: Studies on the Relative Inhibition by alpha 2-Macroglobulin and alpha 1-Antichymotrypsin
Z Chen, K Komatsu, A Prestigiacomo, TA Stamey
The Journal of Urology 1996
A novel protease homolog differentially expressed in breast and ovarian cancer
A Anisowicz, G Sotiropoulou, G Stenman, SC Mok, R Sager
Molecular Medicine 1996
Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen
M Iwamura, J Hellman, AT Cockett, H Lilja, S Gershagen
Urology 1996
A comparative analysis of prostate-specific antigen gene sequence in benign and malignant prostate tissue
R Baffa, JG Moreno, M Monne, ML Veronese, LG Gomella
Urology 1996
In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to α1-antichymotrypsin in blood samples
T Piironen, K Pettersson, M Suonpää, UH Stenman, JE Oesterling, T Lövgren, H Lilja
Urology 1996
Free, complexed and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate
SE Lerner, SJ Jacobsen, H Lilja, EJ Bergstralh, J Ransom, GG Klee, T Piironen, ML Blute, MM Lieber, H Zincke, K Pettersson, D Peterson, JE Oesterling
Urology 1996
Prostate-specific antigen in amniotic fluid of normal and abnormal pregnancies
DN Melegos, H Yu, LC Allen, EP Diamandis
Clinical Biochemistry 1996
Disparate Tissue-specific Expression of Members of the Tissue Kallikrein Multigene Family of the Rat
RJ MacDonald, EM Southard-Smith, E Kroon
The Journal of biological chemistry 1996
Biochemical Characteristics and Recent Biological Knowledge on Prostate-Specific Antigen
E Seregni, C Botti, G Ballabio, E Bombardieri
TUMORI 1996
PSA as a Marker for Prostate Cancer: A Critical Review
MJ Duffy
Annals of Clinical Biochemistry 1996
Molecular Reviews in Cardiovascular Medicine
K Lindpaintner, D Ganten
1996
Carcinoma of the Prostate
Z Petrovich, L Baert, LW Brady
1996
Diagnosis and Treatment of Genitourinary Malignancies
KJ Pienta
1996
Prostate Cancer Old Problems and New Approaches: Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects
KV Honn, A Aref, YQ Chen, ML Cher, JD Crissman, JD Forman, X Gao, D Grignon, M Hussain, AT Porter, JE Pontes, I Powell, B Redman, W Sakr, R Severson, DG Tang, DP Wood
Pathology & Oncology Research 1996
A comparative study of tumor markers of adenocarcinoma prostate
A Saraswathi, T Malati
Indian Journal of Clinical Biochemistry 1995
Evaluation of free psa isoforms, psa complex formation, and specificity of anti-psa antibodies by hplc and page-immunoblotting techniques
JT Wu, P Zhang, T Wang, L Wilson, M Astill
Journal of Clinical Laboratory Analysis 1995
Expression of Active, Secreted Human Prostate-specific Antigen by Recombinant Baculovirus-infected Insect Cells on a Pilot-scale
R Kurkela, A Herrala, P Henttu, H Nal, P Vihko
Bio/Technology 1995
Prostate specific antigen role and function
DM Peehl
Cancer 1995
Proteases in prostate development, function, and pathology
MJ Wilson
Microscopy Research and Technique 1995
Biological activity of prostate-specific antigen isolated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electroelution
U Tessmer, T Quack, F Donn, A Leuner, R Dernick
Electrophoresis 1995
Clearance of serum PSA after open surgery for benign prostatic hypertrophy, radical cystectomy, and radical prostatectomy
F Haab, V Delmas, L Boccon-Gibod, A Meulemans, L Boccon-Gibod, MC Dauge
The Prostate 1995
Diagnostic markers of prostate cancer: Utility of prostate-specific antigen in diagnosis and staging
CT Lee, JE Oesterling
Seminars in Surgical Oncology 1995
Generation, purification, and characterization of a recombinant source of human prostate-specific antigen
R Bei, C Paranavitana, D Milenic, SV Kashmiri, J Schlom
Journal of Clinical Laboratory Analysis 1995
Measurement of c-erbb-2 proteins in sera from patients with carcinomas and in breast tumor tissue cytosols: Correlation with serum tumor markers and membrane-bound oncoprotein
JT Wu, ME Astill, SD Gagon, L Bryson
Journal of Clinical Laboratory Analysis 1995
Prostate-specific antigen activates single-chain urokinase-type plasminogen activator
E Yoshida, S Ohmura, M Sugiki, M Maruyama, H Mihara
International Journal of Cancer 1995
In vivo and in vitro complex formation of prostate specific antigen with αi-anti-chymotrypsin
PR Huber, G Mattarelli, B Strittmatter, GJ van Steenbrugge, HP Schmid, A Maurer
The Prostate 1995
Serum free prostate specific antigen: Isoenzymes in benign hyperplasia and cancer of the prostate
PR Huber, HP Schmid, G Mattarelli, B Strittmatter, GJ van Steenbrugge, A Maurer
The Prostate 1995
New diagnostic applications and physiological functions of prostate specific antigen
EP Diamandis
Scandinavian Journal of Clinical & Laboratory Investigation 1995
Biochemistry of prostate specific antigen, PSA
J Malm, H Lilja
Scandinavian Journal of Clinical & Laboratory Investigation 1995
Standardization of PSA determinations
UH Stenman, J Leinonen, WM Zhang
Scandinavian Journal of Clinical & Laboratory Investigation 1995
Autoantibodies to Prostate Specific Antigen in Patients with Benign Prostatic Hyperplasia
A Zisman, E Zisman, A Lindner, S Velikanov, YI Siegel, E Mozes
The Journal of Urology 1995
Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new era
RT McCormack, TJ Wang, HG Rittenhouse, RL Wolfert, JA Finlay, H Lilja, RL Okoloff, JE Oesterling
Urology 1995
Molecular Cloning, Tissue-specific Expression, and Cellular Localization of Human Prostasin mRNA
JX Yu, L Chao, J Chao
The Journal of biological chemistry 1995
The Impact of PSA on Prostate Cancer Management
JR Gingrich, DF Paulson
Surgical oncology clinics of North America 1995
Biochemical characteristics and biological profile of prostate specific antigen (PSA)
E Seregni, C Botti, G Grasselli, E Bombardieri
1995
PSA in prostate cancer: Criticai evaluation of clinically available assay methods
M Gion, P Barioli
1995
Screening des Prostatakarzinoms
P Faul, JE Altwein
1995
Prostatic kallikreins: biochemistry and physiology
JY Dubé
Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology 1994
The human kallikrein gene family: a diversity of expression and function
JA Clements
Molecular and Cellular Endocrinology 1994
Assay for prostate specific antigen (PSA): Problems and possible solutions
JT Wu
Journal of Clinical Laboratory Analysis 1994
Sperm motility inhibitor from human seminal plasma: presence of a precursor molecule in seminal vesicle fluid and its molecular processing after ejaculation
M Robert, C Gagnon
International Journal of Andrology 1994
Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen
A CHRISTENSSON, H LILJA
European Journal of Biochemistry 1994
Human Eccrine Sweat Contains Tissue Kallikrein and Kininase II
T Hibino, T Takemura, K Sato
Journal of Investigative Dermatology 1994
Value of preoperative PSA in predictingpathologic stage of patients undergoing salvage prostatectomy
E Younes, GP Haas, JE Montie, JB Smith, IJ Powell, JE Pontes
Urology 1994
Prostate-specific antigen in screening of prostate cancer
TM Chu
Journal of Clinical Laboratory Analysis 1994
Prostate cancer
WR Lee, B Giantonio, GE Hanks
Current Problems in Cancer 1994
A structural model for the prostate disease marker, human prostate-specific antigen
BO Villoutreix, ED Getzoff, JH Griffin
Protein Science 1994
First report on purification of the predominant acidic coagulum protein of human semen prior to liquefaction
A Mandal, AK Bhattacharyya
Andrologia 1994
Purification of enzymes of the kallikrein gene family (rK8 and rK9) from the rat prostate
H Schøyen, I Wassdal, K Toft, M Almendingen, T Berg
Biochemical Journal 1994
Prostate-Specific Antigen: Critical Issues for the Practicing Physician
HC Ruckle, GG Klee, JE Oesterling
Mayo Clinic Proceedings 1994
Biochemical and Molecular Aspects of Selected Cancers
E Eigenbrodt, U Gerbracht, S Mazurek, P Presek, R Friis
Biochemical and Molecular Aspects of Selected Cancers 1994
Rapid Inhibition of the Sperm Protease Acrosin by Protein C Inhibitor
JM Hermans, R Jones, SR Stone
Biochemistry 1994
The Prostate Specific Antigen: Its Use as a Tumor Marker for Prostate Cancer
PW Kantoff, JA Talcott
Hematology/Oncology Clinics of North America 1994
Ultrastructure of the Male Urogenital Glands
A Riva, FT Riva, P Motta
1994
Prostasin is a novel human serine proteinase from seminal fluid. Purification, tissue distribution, and localization in prostate gland
JX Yu, L Chao, J Chao
The Journal of biological chemistry 1994
The effect of orgasm on prostate-specific antigen
RF Kropman, W de Kieviet, RC Pelger, PL Venema
World Journal of Urology 1994
Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies
L Hakalahti, P Vihko, P Henttu, R Vihko, H Autio-Harmainen, Y Soini
International Journal of Cancer 1993
Relationship between Prostate Specific Antigen, Prostate Volume and Age in the Benign Prostate
GN Collins, RJ Lee, GB McKELVIE, AC Rogers, M Hehir
British Journal of Urology 1993
Systemic therapy of prostate cancer. new concepts from prostate cancer tumor biology
WS Hsieh, JW Simons
Cancer Treatment Reviews 1993
Production of alpha-1-antichymotrypsin by PSA-containing cells of human prostate epithelium
A Bjartell, T Bjork, MT Matikainen, PA Abrahamsson, A Sant'agnese, H Lilja
Urology 1993
Ability of preoperative serum prostatespecific antigen value to predict pathologic stage and DNA ploidy Influence of clinical stage and tumor grade
E Kleer, JJ Larson-Keller, H Zincke, JE Oesterling
Urology 1993
Fibrinolysis and coagulation markers in seminal plasma before and after vasectomy
JW Wersch, JH Ubachs, KP Delaere
Fibrinolysis 1993
The Effects of Exercise and Activity on Serum Prostate Specific Antigen Levels
EK Leventhal, TA Rozanski, AF Morey, V Rholl
The Journal of Urology 1993
Gelatinolytic And Caseinolytic Proteinase Activities In Human Prostatic Secretions
MJ Wilson, H Norris, D Kapoor, M Woodson, C Limas, AA Sinha
The Journal of Urology 1993
Serum Prostate Specific Antigen Complexed to α 1-Antichymotrypsin as an Indicator of Prostate Cancer
A christensson, T Björk, O Nilsson, U Dahlén, MT Matikainen, AT Cockett, PA Abrahamsson, H Lilja
The Journal of Urology 1993
The Impact of Ejaculation on Serum Prostate Specific Antigen
R Simak, S Madersbacher, ZF Zhang, U Maier
The Journal of Urology 1993
SIGNIFICANCE OF DIFFERENT MOLECULAR FORMS OF SERUM PSA
H Lilja
The Urologic clinics of North America 1993
ISSUES IN THE ASSESSMENT OF PSA IMMUNOASSAYS
RL Vessella, PH Lange
The Urologic clinics of North America 1993
Structure, function, and regulation of the enzyme activity of prostate-specific antigen
H Lilja
World Journal of Urology 1993
Prostate-specific antigen and androgen deprivation therapy
HC Ruckle, JE Oesterling
World Journal of Urology 1993
Prostatic intraepithelial neoplasia and prostate-specific antigen
JR Porter, MK Brawer
World Journal of Urology 1993
A brief review of ultrasensitive prostate-specific antigen assays for the evaluation of patients after radical prostatectomy
TK Takayama, RL Vessella, PH Lange
World Journal of Urology 1993
Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system
M Laurell, A Christensson, PA Abrahamsson, J Stenflo, H Lilja
Journal of Clinical Investigation 1992
Steroids inversely affect the biosynthesis and secretion of human prostatic acid phosphatase and prostate-specific antigen in the LNCaP cell line
P Henttu, P Vihko
The Journal of Steroid Biochemistry and Molecular Biology 1992
Prostate specific antigen predominantly forms a complex with alpha1-antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum
H Lilja, AT Cockett, PA Abrahamsson
Cancer 1992
Prostate-specific antigen and diagnosing early malignancies of the prostate
JE Oesterling
Journal of Cellular Biochemistry 1992
Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP
BT Montgomery, CY Young, DL Bilhartz, PE Andrews, NF Thompson, DJ Tindall, JL Prescott
The Prostate 1992
Characterization of the human kallikrein locus
PH Riegman, RJ Vlietstra, L Suurmeijer, CB Cleutjens, J Trapman
Genomics 1992
Inter-relation between Measurement of Serum Prostatic Specific Antigen and Transrectal Ultrasound in the Diagnosis of Benign Prostatic Hyperplasia and Prostatic Cancer
R Clements, RJ Etherington, GJ Griffiths, WB Peeling, H Hughes, MD Penney
British Journal of Urology 1992
Prostatic Specific Antigen and Immunoglobulin Binding Factor in Human Seminal Plasma and Prostate
ZG Liang, SM Mitsudo, SS Koide
Systems Biology in Reproductive Medicine 1992
Coagulation and Fibrinolysis Markers in Seminal Plasma of Patients under Evaluation for Involuntary Childlessness
JW van Wersch, JC de Vries-Hanje, JM Ubachs
Clinical Chemistry and Laboratory Medicine 1992
Molecular cloning of epididymal and seminal vesicular transcripts encoding a semenogelin-related protein
H Lilja, A Lundwall
Proceedings of the National Academy of Sciences 1992
A sensitive sandwich enzyme immunoassay for γ-seminoprotein and its application to sex discrimination of blood and bloodstains
N Yukawa, T Kohno, E Ishikawa, K Takahama
Forensic Science International 1992
Histochemistry of the prostate
WC Allsbrook, WW Simms
Human Pathology 1992
Effects of Rectal Examination, Prostatic Massage, Ultrasonography and Needle Biopsy on Serum Prostate Specific Antigen Levels
JJ Yuan, DE Coplen, JA Petros, RS Figenshau, TL Ratliff, DS Smith, WJ Catalona
The Journal of Urology 1992
Screening for Prostatic Carcinoma with Prostate Specific Antigen
MK Brawer, MP Chetner, J Beatie, DM Buchner, RL Vessella, PH Lange
The Journal of Urology 1992
Advances in Forensic Haemogenetics
C Rittner, PM Schneider
1992
Can disturbances of the ejaculatory sequence contribute to male infertility?
U Kvist
International Journal of Andrology 1991
Variations in3H-diisopropylfluorophosphate binding proteins in human seminal plasma
G Frenette, RR Tremblay, JY Dubé
International Journal of Andrology 1991
Monoclonal prostate-specific antigen in untreated prostate cancer. Relationship to clinical stage and grade
RJ Babaian, JL Camps, DN Frangos, EI Ramirez, DM Tenney, JS Hassell, HA Fritsche
Cancer 1991
Prostatic Specific Antigen Related to Clinical Status 1 to 14 Years after Radical Retropubic Prostatectomy
A Stein, JB deKERNION, F Dorey
British Journal of Urology 1991
Characterization and Expression of the Prostatic Arginine Esterase Gene, a Canine Glandular Kallikrein
P Chapdelaine, E Gauthier, MA Ho-Kim, L Bissonnette, RR Tremblay, JY Dubé
DNA and Cell Biology 1991
Identification and androgen-regulated expression of two major human glandular kallikrein-1 (hGK-1) mRNA species
PH Riegman, RJ Vlietstra, HA van der Korput, JC Romijn, J Trapman
Molecular and Cellular Endocrinology 1991
Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen
F España, J Gilabert, A Estellés, A Romeu, J Aznar, A Cabo
Thrombosis Research 1991
Prostate-specific antigen and prosttic acid phosphatase: Biomolecular and physiologic characteristics
DL Bilhartz, DJ Tindall, JE Oesterling
Urology 1991
Prostate-specific antigen is not excretedby human kidney or eliminated by routine hemodialysis
JN Kabalin, JC Hornberger
Urology 1991
International Review of Cytology
RA Miller
International Review of Cytology 1991
Prostate Specific Antigen: A review
MK Brawer
Acta Oncologica 1991
Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate
JE Oesterling
The Journal of Urology 1991
Effect of Suramin on Human Prostate Cancer Cells in Vitro
RV la Rocca, R Danesi, MR Cooper, CA Jamis-Dow, MW Ewing, WM Linehan, CE Myers
The Journal of Urology 1991
The evaluation of markers of prostatic function
H von der Kammer, KH Scheit, W Weidner, TG Cooper
Urological Research 1991
Molecular and Cellular Biology of Prostate Cancer
JP Karr, DS Coffey, RG Smith, DJ Tindall
1991
Prostate-Specific Antigen: Questions Often Asked
CS Killian, TM Chu
Cancer Investigation 1990
Species- and organ-specificity of secretory proteins derived from human prostate and seminal vesicles
G Aumüller, J Seitz, H Lilja, PA Abrahamsson, HD von Kammer, KH Scheit
The Prostate 1990
Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors
A CHRISTENSSON, CB LAURELL, H LILJA
European Journal of Biochemistry 1990
Seminal Vesicles: Development, Secretory Products, and Fertility
PT Curry, RW Atherton
Systems Biology in Reproductive Medicine 1990
Cell biology of semenogelin: Zellbiologie von Semenogelin
H Lilja
Andrologia 1990
Analytical biochemistry of seminal vesicle secretion: a challenge to andrological laboratories: Analytische Biochemie des Bläschendrüsensekrets: eine Herausforderung für das andrologische Labor
M Balerna, G Medici, L Mazzucchelli, T Bianda, L Marossi, GM Colpi
Andrologia 1990
Three predominant prostatic proteins: Drei vorherrschende Prostataproteine
PA Abrahamsson, H Lilja
Andrologia 1990
Isolation of a new actin-binding protein from human seminal plasma
K Akiyama, H Kimura
Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1990
Characterization of a monoclonal antibody specific for prostatic secretory protein of 94 amino acids (PSP94) and development of a two-site binding enzyme immunoassay for PSP94
H der Kammer, E Krauhs, G Aumüller, KH Scheit
Clinica Chimica Acta 1990
In Situ Hybridization of Prostate-Specific Antigen mRNA in Human Prostate
SD Qiu, CY Young, DL Bilhartz, JL Prescott, GM Farrow, WW He, DJ Tindall
The Journal of Urology 1990
Identity of Prostate Specific Antigen and the Semen Protein P30 Purified by a Rapid Chromatography Technique
HC Graves, M Kamarei, TA Stamey
The Journal of Urology 1990
Cancer Markers of the 1990s: Comparison of the New Generation of Markers Defined by Monoclonal Antibodies and Oncogene Probes to Prototypic Markers
S Sell
Clinics in Laboratory Medicine 1990
Das Prostatakarzinom
G Staehler, PG Fabricius
1990
Laboratory Studies for the Detection of Carcinoma of the Prostate
MK Brawer
The Urologic clinics of North America 1990
Prostate-Specific Antigen: Its Role in Early Detection, Staging, and Monitoring of Prostatic Carcinoma
MK Brawer, PH Lange
Journal of Endourology 1989
Characterization of the Prostate-specific Antigen gene: A novel human kallikrein-like gene
PH Riegman, RJ Vlietstra, JA der Korput, JC Romijn, J Trapman
Biochemical and Biophysical Research Communications 1989
Kallikrein-related protease in the rat ventral prostate: cDNA cloning and androgen regulation
J Winderickx, K Swinnen, PV Dijck, G Verhoeven, W Heyns
Molecular and Cellular Endocrinology 1989
Immunocytochemistry of Male Reproductive Organs
DK Kapur, GK Ahuja
Systems Biology in Reproductive Medicine 1989
Zinc Binding to Major Human Seminal Coagulum Proteins
G Frenette, RR Tremblay, JY Dubé
Systems Biology in Reproductive Medicine 1989
The Concentration of Immunoreactive Prostate Specific Antigen is not Decreased in Viscous Semen Samples/Keine Konzentrationsverminderung des immunoreaktiven Prostata-spezifischen Antigens in viskosen Ejakulaten
JY Dubé, D Gaudreault, RR Tremblay
Andrologia 1989
Prostate-specific antigen in management of prostatic carcinoma
MK Brawer, PH Lange
Urology 1989
The prostate-specific antigen gene and the human glandular kallikrein-1 gene are tandemly located on chromosome 19
PH Riegman, RJ Vlietstra, P Klaassen, JA der Korput, AG Kessel, JC Romijn, J Trapman
FEBS Letters 1989
Characterization of the gene for prostate-specific antigen, a human glandular kallikrein
Å Lundwall
Biochemical and Biophysical Research Communications 1989
cDNA coding for the entire human prostate specific antigen shows high homologies to the human tissue kallikrein genes
P Henttu, P Vihko
Biochemical and Biophysical Research Communications 1989
Demonstration of the Role of Prostate-Specific Antigen in Semen Liquefaction by Two-Dimensional Electrophoresis
C Lee, M Keefer, ZW Zhao, R Kroes, L Berg, X Liu, J Sensibar
Journal of andrology 1989
Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. I. Untreated Patients
TA Atamey, JN Kabalin
The Journal of Urology 1989
The Influence of Reversible Androgen Deprivation on Serum Prostate-Specific Antigen Levels in Men with Benign Prostatic Hyperplasia
JP Weber, JE Oesterling, CA Peters, AW Partin, DW Chan, PC Walsh
The Journal of Urology 1989
Clinical use of Prostate Specific Antigen in Patients with Prostate Cancer
MA Hudson, RR Bahnson, WJ Catalona
The Journal of Urology 1989
New Cancer Markers
MJ Duffy
Annals of Clinical Biochemistry 1989
Semenogelin, the Predominant Protein in Human Semen
H Lilja, PA Abrahamsson, Å Lundwall
The Journal of biological chemistry 1989
Morphologic and regulatory aspects of prostatic function
G Aumller
Anatomy and Embryology 1989
Three predominant proteins secreted by the human prostate gland
H Lilja, PA Abrahamsson
The Prostate 1988
Kallikreins, kinins and growth factor biosynthesis
CC Drinkwater, BA Evans, RI Richards
Trends in Biochemical Sciences 1988
Molecular biology of tissue kallikrein
RJ MacDonald, HS Margolius, EG Erdös
Biochemical Journal 1988
High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen
P Chapdelaine, G Paradis, RR Tremblay, JY Dubé
FEBS Letters 1988
Nucleotide sequence of the androgen-dependent arginine esterase mRNA of canine prostate
P Chapdelaine, MA Ho-Kim, RR Tremblay, JY Dubé
FEBS Letters 1988
Molecular cloning and characterization of novel prostate antigen cDNA's
PH Riegman, P Klaassen, JA der Korput, JC Romijn, J Trapman
Biochemical and Biophysical Research Communications 1988
Structure and function of prostatic- and seminal vesicle-secreted proteins involved in the gelation and liquefaction of human semen
H Lilja
Scandinavian Journal of Clinical & Laboratory Investigation 1988
Androgen dependence of specific kallikrein gene family members expressed in rat prostate
JA Clements, BA Matheson, DR Wines, JM Brady, RJ MacDonald, JW Funder
The Journal of biological chemistry 1988
Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen
H Lilja, J Oldbring, G Rannevik, CB Laurell
Journal of Clinical Investigation 1987
Prostate-specific antigen superior serum marker for prostatic carcinoma
JA Heaney, MA Allen, T Keane, MJ Duffy
Irish Journal of Medical Science 1987
Immunoelectron microscopic localization of prostatic-specific antigen in human prostate by the protein a-gold complex
AA Sinha, MJ Wilson, DF Gleason
Cancer 1987
The chymotrypsin-like activity of human prostate-specific antigen, γ-seminoprotein
K Akiyama, T Nakamura, S Iwanaga, M Hara
FEBS Letters 1987
Molecular cloning of human prostate specific antigen cDNA
Å Lundwall, H Lilja
FEBS Letters 1987
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
TA Stamey, N Yang, AR Hay, JE McNeal, FS Freiha, E Redwine
New England Journal of Medicine 1987
Identification and expression of kallikrein gene family in rat submandibular and prostate glands using monoclonal antibodies as specific probes
J Chao, L Chao
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1987
Vasodepressor Hormones in Hypertension: Prostaglandins and Kallikrein-Kinins
G Bönner, OA Carretero, H Küppers, JC McGiff
1987
Human prostate-specific antigen: structural and functional similarity with serine proteases
KW Watt, PJ Lee, T M'Timkulu, WP Chan, R Loor
Proceedings of the National Academy of Sciences 1986
Purification and characterization of rat urinary esterase A1
M Nakamura, M Takaoka, M Nishii, S Morimoto
Biochimica et Biophysica Acta (BBA) - General Subjects 1986

← Previous 1 2 3 4 5 6 … 21 22 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 11 patents
137 readers on Mendeley
See more details